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Bipolar Disorder (BD) is one of the leading causes of disability worldwide. Much of the 
disability associated with BD is linked to the early onset of the disorder, typically 
between 16 and 30 years of age. The aim of the PhD was to examine whether subclinical 
manic symptoms are associated with subsequent onset BD and to identify the 
longitudinal trajectories associated with conversion to syndromal BD.  
 
Methods 
I analyzed data from TRAILS (TRacking Adolescents’ Individuals Lives Survey), a 
prospective population based study of 2,230 Dutch adolescents. Participants were 
assessed with the Child Behaviour Checklist 6-18 (CBCL 6-18) at ages 11, 13 and 16 years 
and were administered the Composite International Diagnostic Interview (CIDI) at age 
19. The prevalence rate for BD in TRAILS was 5.4%.  
 
Results  
I developed and validated a new scale, the Child Behaviour Checklist-Mania Scale (CBCL-
MS) to capture subclinical manic symptoms. The CBCL-MS consists of 19 items of the 
CBCL 6-18 selected by an expert panel to map onto the DSM criteria for Mania. The 
CBCL-MS had a four factor structure that was interpretable and temporally stable, and 
presented with good reliability and discriminative ability for BD. Based on assessments 
with the CBCL-MS at age 11, a Latent Class Analysis extracted three classes, representing 
an asymptomatic class (n=862), a mildly symptomatic class (n=845) and a highly 
symptomatic class (n=199). Membership in the highly symptomatic class was associated 
with a 7-fold increase in the odds for subsequent BD. Non-conversion to BD for 
members of this class was characterised by a decreasing longitudinal trajectory of 






These results support the concept of “alarm symptoms” in BD, as highly deviant 
childhood manic symptoms were associated with a subsequently greatly elevated risk of 
BD, and for initiatives to identify underlying BD at an earlier and more amenable stage. 
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Abstract 
Psychiatric epidemiology has made significant contributions to the identification of   risk 
factors for mental disorders. Available evidence underscores the complexity of the 
interactions between risk and disease and highlights conceptual and methodological 
challenges particularly in examining risk and disease relations beyond the level of simple 
associations. We propose that a life course approach in the study of risk factors for 
mental disorders, combined with fast developing analytical statistical tools, is the most 
promising avenue towards shifting the focus of the field from associations to generating 
and testing aetiological hypotheses. This review presents the basic tenants of life course 
risk modelling, highlights key examples in the available literature that demonstrate the 
potential of this approach to advance our understanding of the trajectories from risk to 
disease and discusses priorities for future research.   
 
 







Psychiatric epidemiology and especially analytical epidemiological studies have made 
great advances in identifying multiple risk factors for mental disorders, particularly for 
schizophrenia, mood disorders and anxiety disorders. Across diagnostic categories key  
risk factors include low Socioeconomic Status (SES) (Danese et al., 2009), familial 
psychopathology (Lichtenstein et al., 2009), Stressful Life Events (SLEs) (Kendler, 
Karkowski, & Prescott, 1999), low IQ (Koenen et al., 2009), family dysfunction (Bouma et 
al., 2008) and cannabis use (Degenhardt et al., 2007). Although informative, these 
reports are commonly limited to simple associations between a risk exposure and a later 
adverse mental health outcome while the timing and exact mechanism of this transition 
remain largely unstudied. Here we advocate a life course approach in the study of risk 
factors for mental disorders as this has the potential to advance our understanding of 
the trajectories from risk to disease. 
 
Within the current cohort designs, life course formulations have the potential to shed 
light in the mechanisms as well as the timing of exposures underlying the development 
of psychopathology, especially when combined with the appropriate analytical 
statistical tools. The objectives of this article are threefold: a) to complement recent 
reviews on early risk factors and genetic variants for common mental disorders, e.g. 
schizophrenia (Brown and Derkits, 2009), by highlighting the additional value of the life 
course approach; b) to present the basic concepts of life course risk modelling; and c) to 
highlight key examples for its usefulness for medicine, psychiatry and public health. The 
examples presented provide evidence on how the life course approach can serve as the 
starting point in addressing questions about mechanisms mediating between risk and 
disease outcome on a more fundamental level. Finally, we make specific suggestions as 
to how life course modelling can be more fully integrated into psychiatric 
epidemiological research. Such information is crucial in moving the field from an 




2. Life Course Approaches in Epidemiology 
 
The life course approach was mostly developed within the field of cardiovascular 
medicine from which we draw key examples to illustrate its two basic tenants, namely 
critical periods and accumulated risk (Lynch and Smith, 2005). 
 
2.1 Critical Periods 
Life course models recognise that the timing of exposure plays an important role in 
determining the risk for disease. In this context life course models focus on critical or 
sensitive periods. The critical period model assumes that there are stages in human 
development during which the influence of external agents may have crucial effects that 
cannot be altered by subsequent events and precipitate disease in later life. Conversely, 
the influence of the same agents during any other developmental stage will be minimal 
or absent. Implicit in the critical period model is the notion that the influence of external 
agents, when it occurs during this particular stage, alters the function or structure of 
biological tissues or systems through processes of “biological programming” so that the 
effect of the exposure becomes “embodied” (Kuh et al. 2003). In contrast, sensitive 
periods are stages in development when the influence of external agents may have the 
strongest effect on disease risk that could be however modified by subsequent 
experiences or exposures (Kuh et al 2003). At this particular junction, the distinction 
between critical and sensitive periods is often blurred as the basic biological effects of 
exposures that could result in altered “biological programming” are poorly understood. 
For simplicity and parsimony we will refer to all models focusing on the timing of 
exposures as critical period models.  
 
The best evidence for the critical period concept derives from the foetal origin 
hypothesis in cardiovascular medicine. It proposes that adversity very early in 
pregnancy, and especially poor maternal nutrition, leads to impaired growth and 




later in life (Barker, 1995; Barker and Clark, 1997; Barker and Osmond, 1986; Eriksson et 
al., 2001; Painter et al., 2006). The incidence of Coronary Artery Disease (CAD) is 
increased following exposure to famine in the first trimester of gestation but not if 
exposure to famine occurs in mid- or late gestation (Painter et al. 2006). 
 
 2.2 Accumulation of Risk 
The accumulation of risk model suggests that exposures or insults act in a cumulative 
fashion to gradually increase the risk of disease or mortality. This hypothesis postulates 
that cumulative differential life time exposure is the main explanation for observed 
individual differences in disease risk (Kuh et al., 2003). Numerous studies have examined 
the risk accumulation hypothesis in relation to medical outcomes, health inequalities 
and social, physical and cognitive functioning (Power et al., 1996; Lynch et al., 1997; 
Smith et al., 1997; Hart et al., 1998; Power et al., 1999; Holland et al., 2000; Wamala et 
al., 2001). There are two main variations to the risk accumulation hypothesis relating to 
whether there is prolonged exposure to a single risk factor or an interaction between 
multiple factors either in an additive (risk clustering)  or in a sequential fashion (chains 
of risk) (Kuh et al. 2003).  
 
A typical example for the prolonged exposure model was provided by Smith and 
colleagues (1997). They employed a prospective observational study design with a 21 
year follow-up focusing on mortality. They examined the risk of lower SES  at three time 
points, in childhood based on father’s occupation and in early and late adulthood 
respectively based on own first and more established occupation. They found a 
cumulative effect of lower SES  acting over the lifetime; people who reported belonging 
to the low SES group at a single measurement point had a relative death rate of 1.29 
(95% CI 1.08-1.56) which increased further to 1.71 (95% CI 1.46-2.01) for those 
reporting belonging to the low SES group at all three measurement points. Similarly, 
Wamala et al (2001) report that, in women, early and late socioeconomic advantage are 




increase in the risk for Coronary Heart Disease (CHD). However, women with both early 
and late exposure had an even greater risk of 4.22 (95% CI 1.4-12.1).  
 
We now focus on how risk factors may interact to increase risk. Different risk factors 
may cluster together and may act cumulatively to increase risk. For example, Luchsinger 
et al (2005) demonstrated by following 1,138 individuals for 5.5 years that diabetes, 
hypertension, heart disease, and smoking were all associated with a higher risk of 
Alzheimer’s disease. In a subsample of people in high risk for Alzheimer’s Disease 
(N=246) the risk conferred by the risk factors individually ranged from 1.4 to 3.6 
(adjusted for age and gender). The hazards ratios of the interactions between these 
factors varied greatly and were highest for the interaction of diabetes and smoking 
which reached 13.7 (95% CI 1.8-101.7).  
 
Alternatively, risk factors may be linked forming chains of risk or insults whereby each 
exposure may lead to further adverse exposures or experiences. Each link in the chain 
may have an independent effect on disease risk or else disease onset may be predicated 
only by the final link (trigger effect) (Kuh et al 2003).  Dong et al. (2004) provide a 
detailed example of this model in relationship to ischemic heart disease. They mapped 
the pathway from childhood adversities (including abuse, neglect and household 
dysfunction) to increased reactivity to stress leading to increased risk for negative 
affective states.  Negative affective states (depression or anger) are now known to cause 
haemodynamic, hemostatic, immunologic and other endocrine changes leading to 
alterations in the platelet function and increased risk of coronary ischemia.   
 
3. Life Course Approaches within the Psychiatric Epidemiological Research 
Within psychiatric epidemiology, cohort designs have the greatest potential to shed 
light on causal mechanisms by which exposure to risk can lead to the development of 
mental disorders. They provide a framework for overcoming recall biases and allow the 




provide data amenable to life course analyses and are therefore the ideal ground for 
generating and testing aetiological models for mental health. The most prominent birth 
cohorts include the Dunedin Multidisciplinary Health and Development Study (DMHDS) 
(Silva, 1990), the British 1946 Birth Cohort (BBC) (Wadsworth, 1987), the National Child 
Development Study (NCDS) (Power and Elliott, 2006), the 1970 British Cohort Study 
(BCS) (Ferry et al., 2003), the Northern Finland 1966 Birth Cohort (NFBC) (Rantakallio, 
1988), the Child Health and Development Study (CHDS) (Van den Berg et al.,1988) and 
the Christchurch Health and Development Study (ChrHDS) (Fergusson and Horwood, 
2001). For these studies, 1,000 to 20,000 individuals from well defined-geographical 
areas were assessed from pregnancy or birth and were followed-up at regular intervals 
with low to moderate attrition rates. Follow-up periods have been of sufficient length so 
as to capture sufficient cases of schizophrenia, depression or anxiety disorders. Findings 
stemming from birth cohorts have substantially contributed to the field of translational 
epidemiologic research, a term used to describe the application of findings into 
innovative primary and secondary interventions and therefore into new clinical 
practices and public health policies (Weissman et al., 2011). Figure 1 summarizes some 
of the evidence identified and illustrates the notions of critical periods and accumulation 
of risk while assuming that the risk conferred by genetic factors is constant.  
 
 3.1 Critical Periods 
Most of psychiatric epidemiology has focused on the notion of critical periods with main 
emphasis on the foetal and adolescent periods. Similarly to medical disorders, prenatal 
exposure to famine has been also shown to play a significant role for the development 
of mental disorders. Brown et al (2000) provide an early example of significant 
associations between exposures to prenatal famine during the second and third 
trimester and major affective disorder in adulthood. Exposures to the rubella (Brown et 
al., 2001) and the influenza virus (Brown et al., 2004) during pregnancy are strongly 
associated with adult schizophrenia; specifically, the risk for psychotic illness in 




virus during the first trimester of gestation. In contrast, exposure to the same virus 
during the second or third trimester confers smaller risk [2nd trimester: 1.1 (95% CI 0.3-
3.9); 3rd trimester: 1.1 (95% CI 0.5-2.6)].  
 
Adolescence is also commonly considered a critical period because of documented 
evidence for brain maturation processes (Whitford et al., 2007) and hormonal changes 
(Sisk and Zehr, 2005). Cannabis use during adolescence is a frequently studied risk factor 
for the development of psychosis (Figure 1). Cannabis use at age 14-15 years appears to 
increase the risk of psychosis in adulthood by 4.50 (95% CI 1.11 to 18.21) while the risk 
for users at age 18 is substantially lower(1.65; 95% CI 0.65 to 4.18) (Arseneault et al., 
2002) and is similar to that observed following cannabis use in early adulthood [1.68 
(95% CI 0.37–7.51)] (Grech et al., 2005). 
 
 3.2 Accumulation of Risk 
Relatively fewer studies have examined the accumulation of risk models with most 
recent examples focusing on the role of cannabis. In addition to influencing risk during 
critical periods, the effect of cannabis on the risk for psychosis increases further the 
greater and more prolonged the duration of exposure (Grech et al., 2005; Semple et al., 
2005) (as illustrated in Figure 1). Furthermore, cannabis appears to act synergistically 
with other risk factors to increase and maintain the risk for psychosis (Cougnard et al., 
2007; Houston et al., 2008; Harley et al., 2010). A typical example is provided by Harley 
et al (2010), who examined the interactions between childhood trauma and cannabis 
use with respect to the development of psychotic symptoms (Figure 1). In their study 
each risk factor independently increased the risk of psychotic symptoms. The individual 
risk conferred was 2.6 (95% CI 0.25–14.6) for childhood trauma and 1.9 (95% CI 0.04–
16.5) for cannabis use.  However, the interaction of childhood trauma and cannabis use 





In terms of chains of risk research in depression has yielded the most consistent findings 
to date. A common cascade of exposures leading to depression begins with maternal 
depression which increases the risk of family adversity (Murray et al., 1996) leading to 
increased reactivity to stress reflected in Hypothalamic-Pituitary Adrenal (HPA) axis 
dysregulation (Halligan et al., 2004).  Increased stress reactivity increases the risk of 
negative affect during adverse life exposures and further disrupts the HPA axis. This has 
been associated with reduced hippocampal volume and prefrontal cortical activation 
which increase the risk of clinical depression (Palazidou, 2012).  
 
Accumulation of risk and critical periods are not two mutually exclusive models. 
Shanahan and Hofer (2011) have recently described how such life course models could 
explain the interaction between genetic and social risk factors of disease. They posit 
that exposure to certain social risk factors during critical or sensitive periods may not 
only impact on biological structure or functions but may greatly influence subsequent 
social experiences forming a “chain of insults” and resulting in cumulative disadvantage.   
 
The studies highlighted illustrate the potential of life course approach in disentangling 
the complex architecture of risk for psychiatric disorders and in providing a deeper 
understanding of how different life course models might complement each other.  
These theoretical models when paired with fast developing statistical techniques 
present new opportunities for the investigation of the mechanisms of conversion to 
psychopathology.  
 
 3.3 Traditional multivariate analyses vs. advanced statistical modeling techniques 
A statistical model is formally defined as a set of probability distributions on the sample 
space (McCullagh, 2002), but can be simply conceptualized as the explanation of the 
relationships between variables using mathematical equations. To date, the most 
commonly used modelling approaches in psychiatric epidemiology have been linear and 




employing a life time approach for two main reasons; first, they cannot estimate 
separate regression lines for each individual (i.e. they neglect important information on 
inter-individual variability) and second they rely on the assumption that the intercept 
and rate of change (slope) of additional explanatory variables are error free (Bollen and 
Curran, 2006).  
 
These limitations can now be tackled by utilising different analytical tools that broadly 
fall under category of Structural Equation Modelling (SEM). These include but not 
restricted to Latent Growth Models (LGMs), Multivariate LGMs with or without Time In-
varying Covariates (TICs) and Time Varying Covariates (TVCs), Autoregressive Latent 
Trajectory models (ALTs) ( McArdle and Hamagami, 1992; Curran and Hussong, 2003; 
Bollen and Curran, 2004; Ludtke et al., 2008; MacKinnon, 2008; Rabe-Hesketh and 
Skrondal, 2008; Chavance et al., 2010 ). The main advantage of these models is that they 
provide the framework to overcome the implicit assumption of no unmeasured 
confounding within life course approaches. The central aim of psychiatric research on 
risk factors of mental disorders using life course approaches is the search for causative 
relationships between exposures and outcomes. Causal inference is best addressed 
using Randomized Control Trials (RCTs). Within the life course approach framework one 
of the main challenges for causal inferences has been to tackle the assumption of no 
additional confounding due to unmeasured factors (Gilman, 2007). Linear and non-
parametric SEMs have now been used as alternative methods that allow researchers to 
make causal inferences in the presence of unmeasured confounders (Pearl, 2000; 
Hernan and Robins, 2006; Martens et al., 2006). Additionally, LGMs can identify the 
unique change in the variance of the slope and rate of growth of variables within and 
across individuals. This type of information would address questions concerning critical 
periods of exposure and accumulation of risk more precisely. Specifically, these models 
allow for a) detecting patterns of non-linear change, e.g. quadratic or cubic functions 
(LGMs); b) incorporating repeated measures of a covariate as a direct predictor of the 




that dependent variable (Multivariate LGMs); c) expressing the repeated measures of a 
variable as a function of a set of parameters while implying that later observations are a 
direct function of earlier observations plus some time-specific error (ALTs).  
 
As an example we can examine recent findings on cognitive functioning in patients with 
schizophrenia. The meta-analysis by Woodberry and colleagues (2008) suggested that 
cross-sectional designs can only demonstrate that patients have IQ deficit at different 
time points but are unable to address the persistent question of whether IQ declines 
within individuals with illness progression. In response Reichenberg et al (2010) 
modeled the cognitive trajectories prior to schizophrenia onset using latent growth 
curves by utilizing the DMHDS sample. This constitutes a sensitive approach in terms of 
identifying the unique variability in the growth rate of IQ at multiple measurement 
points with the potential to identify a) the temporal relationship between IQ decline and 
illness onset and b) non-linear trajectories of developmental deficits. Therefore, 
Reichenberg and colleagues were able to delineate the differences in the developmental 
course of various cognitive functions from childhood to early adolescence (Figure 2) and 
to identify the pre-morbid decline in executive function associated with schizophrenia. 
Similar approaches have been successfully applied in other areas of epidemiological 
research (e.g. Chen et al., 2007). 
 
Despite the availability of longitudinal cohorts epidemiological psychiatric research to 
date presents with four key limitations. Firstly, examination of critical periods has been 
limited to narrow developmental windows (instead of taking a life course perspective) 
and to one or two risk factors (Ben-Shlomo and Kuh, 2002). Secondly, the few studies 
that have examined accumulation of risk models have been limited primarily by 
retrospective or cross-sectional data collection (Clemmons et al., 2007; Picken et al., 
2010). Thirdly, even studies based on prospective data, have commonly focused on the 
association between a range of risk factors and outcome. Thus they account only for a 




between risk factors. Moreover, the frequent use of composite indices obscures the 
temporal effects of risk factors and fails to distinguish between critical periods and 
accumulation of risk (Jaffee et al., 2002; Koenen et al., 2007). Fourthly, there is 
considerable lack of clarity between measures that constitute risk factors and measures 
that reflect health outcomes. For example, although cannabis use in adolescence is a 
risk factor for psychosis (Arseneault et al., 2002; Fergusson et al., 2003), substance 
abuse can also be considered an adverse diagnostic outcome (Fergusson et al., 1994; 
Fergusson et al., 1996; Koenen et al., 2009; Melchior et al., 2007; Woodward and 
Fergusson, 2001).   
 
4. Directions for Future Research 
There has been tremendous progress in our understanding of risk factors and their 
possible immediate and long-term effects, either independently or in combination. 
However, there is still much potential for further advancement.  We have advocated the 
benefits of a systematic implementation of life-course models to epidemiological 
research in psychiatry. This is particularly timely given the recent wider availability of 
the necessary computational and statistical instruments required. Below we make 
specific suggestions with regards to the research areas to be prioritised.  
 
A lifecourse approach could advance the field in at least five distinct directions. Firstly, 
by interrogating available data it would be possible to identify critical periods beyond 
the early years or life. An example could be exploring the possibility that in women 
perimenopausal estrogen decline (Seeman, 2010) may trigger a late “critical period” for 
the onset of schizophrenia between the ages of 45 to 50 years (Häfner, 2005). Secondly, 
the impact of risk factors may change in magnitude across the lifespan. This has been 
shown with regards to developmental trajectories for cognitive risk factors in 
schizophrenia (e.g. Kremen et al.,2008; Reichenberg, et al., 2010). Thirdly, Kendler et al. 
(2010) suggested that the effects of interactions of risk factors are of secondary 




background. Therefore, modelling of interactions should proceed by testing the 
robustness of different theoretical assumptions with regards to the timing and 
conditions under which risk factors may influence disease onset.  Fourthly, most studies 
to date have considered the effect of risk factors on a single outcome. Relatively less is 
known about the possibility of a particular risk factor increasing the probability for 
variable outcomes. Such a pluripotent effect of risk factors has been shown for  family 
history of schizophrenia which increases the probability of multiple other adverse 
mental health outcomes (Dean et al., 2010).  Focusing on the variability of outcome has 
the added advantage that it may lead to identification of protective factors against 
adverse mental health and will allow modelling future interventions not simply on risk 
minimisation but also enhancement of resilience. Fifthly, implicit in all current research 
is the notion that risk factors, particularly those in early life, are “embodied” or in other 
words, that they produce an irreversible biological changes which then influences adult 
health outcomes. The logical next step is to identify the relevant biological pathways as 
a means towards identification of causative mechanisms underlying disease expression. 
A recent example is provided by Ledergoben et al (2011) with regards to urbanicity, a 
factor known to increase the incidence and prevalence of a range of mental disorders. 
The authors found that urbanicity was associated with increased activation in the 
amygdala and anterior cingulate cortex during cognitive tasks when they were 
performed under conditions of social stress (Lederbogen et al., 2011).   
 
In sum, the evidence we have presented points to new avenues in study design and data 
analysis. It is our view that there are three priority areas, namely a) modelling and 
testing pathways showing how risk factors might relate to critical periods of biological 
development, b) assessing the cumulative effect following prolonged exposure or the 









Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A., & Moffitt, T. E., 2002. 
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. 
British Medical Journal 325, 1212-1213. 
 
Barker, D. J., 1995. Fetal origins of coronary heart disease. British Medical Journal 311, 
171-174. 
 
Barker, D. J., Clark, P. M., 1997. Fetal undernutrition and disease in later life. Reviews of 
Reproduction  2, 105-112. 
 
Barker, D. J., Osmond, C., 1986. Infant mortality, childhood nutrition, and ischaemic 
heart disease in England and Wales. Lancet 1, 1077-1081. 
 
Ben-Shlomo, Y., Kuh, D., 2002. A life course approach to chronic disease epidemiology: 
conceptual models, empirical challenges and interdisciplinary perspectives. 
International Journal of Epidemiology 31, 285-293. 
 
Bollen, K. A., Curran, P. J., 2004. Autoregressive latent trajectory  models: a synthesis of 
two traditions. Sociological Methods and Research 32, 336-383. 
 
Bollen, K. A., Curran, P. J., 2006. Latent curve models: a structural equation perspective. 
New Jersey: Wiley-Interscience. 
 
Bouma, E. M., Ormel, J., Verhulst, F. C., Oldehinkel, A. J., 2008. Stressful life events and 
depressive problems in early adolescent boys and girls: the influence of parental 





Brown, A. S., Begg, M. D., Gravenstein, S., Schaefer, C. A., Wyatt, R. J., Bresnahan, M., 
Babulas, V.P., Susser, E.S., 2004. Serologic evidence of prenatal influenza in the etiology 
of schizophrenia. Archives of General Psychiatry 61, 774-780. 
 
Brown, A. S., Cohen, P., Harkavy-Friedman, J., Babulas, V., Malaspina, D., Gorman, J. M., 
Susser, E.S.,2001. Prenatal rubella, premorbid abnormalities, and adult schizophrenia. 
Biological Psychiatry 49, 473-486. 
 
Brown, A.S., Derkits, E.J., 2009. Orenatal Infection and Schizophrenia: A Review of 
EPidemiologic and Translational Studies. American Journal of Psychiatry 167, 261-280. 
 
Brown, A. S., van Os, J., Driessens, C., Hoek, H. W., Susser, E. S., 2000. Further evidence 
of relation between prenatal famine and major affective disorder. American Journal of 
Psychiatry 157, 190-195. 
 
Chavance, M., Escolano, S., Romon, M., Basdevant, A., de Lauzon-Guillain, B.,  
Charles, M. A., 2010. Latent variables and structural equation models for longitudinal  
relationships: an illustration in nutritional epidemiology. BMC Medical Research  
Methodology 10, 37-63. 
 
Chen, H., Cohen, P., Kasen, S, 2007. Cohort differences in self-rated health: evidence 
from a three-decade, community-based, longitudinal study of women. American ournal 
of Epidemiology 166, 439-446. 
 
Clemmons, J. C., Walsh, K., DiLillo, D., Messman-Moore, T. L., 2007. Unique and 
combined contributions of multiple child abuse types and abuse severity to adult 





Cougnard, A., Marcelis, M., Myin-Germeys, I., De Graaf, R., Vollebergh, W., Krabbendam, 
L., Lieb, R., Wittchen, H.U., Henquet, C., Spauwen, J., Van Os, J., 2007. Does normal 
developmental expression of psychosis combine with environmental risk to cause 
persistence of psychosis? A psychosis proneness-persistence model. Psychological 
Medicine 37, 513-527. 
 
Curran, P. J., Hussong, A. M., 2003. The use of latent trajectory models in  
psychopathology research. Journal of Abnormal Psychology 112, 526-544. 
 
Danese, A., Moffitt, T. E., Harrington, H., Milne, B. J., Polanczyk, G., Pariante, C. M., 
Poulton, R., Caspi, A.,2009. Adverse childhood experiences and adult risk factors for age-
related disease: depression, inflammation, and clustering of metabolic risk markers. 
Archives of Pediatrics and Adolescent Medicine 163, 1135-1143. 
 
Dean, K., Stevens, H., Mortensen, P. B., Murray, R. M., Walsh, E., Pedersen, C. B., 2010. 
Full spectrum of psychiatric outcomes among offspring with parental history of mental 
disorder. Archives of General Psychiatry 67, 822-829. 
 
Degenhardt, L., Tennant, C., Gilmour, S., Schofield, D., Nash, L., Hall, W., McKay, D.,2007. 
The temporal dynamics of relationships between cannabis, psychosis and depression 
among young adults with psychotic disorders: findings from a 10-month prospective 
study. Psychological Medicine 37, 927-934. 
 
Dong, M., Giles, W.H., Felitti, V.J., Dube, S.R., Williams, J.E., Chapman, D.P., Anda, R.F., 
2004. Insights into causal pathways for ischemic heart disease: adverse childhood 





Eriksson, J. G., Forsen, T., Tuomilehto, J., Osmond, C., Barker, D. J., 2001. Early growth 
and coronary heart disease in later life: longitudinal study. British Medical Journal 322, 
949-953. 
 
Fergusson, D. M., Horwood, L. J., Lynskey, M., 1994. The childhoods of multiple problem 
adolescents: a 15-year longitudinal study. The Journal of Child Psychology and 
Psychiatry 35, 1123-1140. 
 
Fergusson, D. M., Horwood, J. L., 2001. The Christchurch Health and Development  
Study: Review of Findings on Child and Adolescent Mental Health. Australian and  
New Zealand Journal of Psychiatry 35, 287-296.  
 
Fergusson, D. M., Horwood, L. J., Swain-Campbell, N. R., 2003. Cannabis dependence 
and psychotic symptoms in young people. Psychological Medicine 33, 15-21. 
 
Fergusson, D. M., Lynskey, M. T., Horwood, L. J., 1996. Comorbidity between depressive 
disorders and nicotine dependence in a cohort of 16-year-olds. Archives of General 
Psychiatry 53, 1043-1047. 
 
Ferry, E., Bynner, J., Wadsworth, M., 2003. Changin Britain, Changing Lives: Three  
Generations at the Turn of the Century, Institute of Education, University of London. 
 
Gilam, S.E., 2007. Invited Commentary: The Life Course Epidemiology of Depression. 
American Journal of Epidemiology 166, 1134-1137. 
 
Grech, A., Van Os, J., Jones, P. B., Lewis, S. W., Murray, R. M., 2005 Cannabis use and 





Häfner, H., 2005. Gender differences in schizophrenia. In R.-R. A. Bergemann N (Ed.), 
Estrogen effects in psychiatric disorders (pp. 53-94). Vienna: Springer-Verlag. 
Halligan, S.L., Murray, L., Martins, C., Cooper, P.J., 2007. Maternal depression and 
psychiatric outcomes in adolescent offspring: A 13-year longitudinal study. Journal of 
Affective Disorders 97, 145-154. 
 
Harley, M., Kelleher, I., Clarke, M., Lynch, F., Arseneault, L., Connor, D., et al., 2010. 
Cannabis use and childhood trauma interact additively to increase the risk of psychotic 
symptoms in adolescence. Psychological Medicine 40, 1627-1634. 
 
Hart, C. L., Smith, G. D., Blane, D., 1998. Inequalities in mortality by social class 
measured at 3 stages of the lifecourse. American Journal of Public Health 88, 471-474. 
 
Hernan, M.A., Robins J.M., 2006. Instruments for Causal Inference: An Epidemiologist's 
Dream? Epidemiology, 17, 360-372. 
 
Holland, P., Berney, L., Blane, D., Smith, G.D., Gunnell, D. J., Montgomery, S. M., 2000. 
Life course accumulation of disadvantage: childhood health and hazard exposure during 
adulthood. Social Science and Medicine  50, 1285-1295. 
 
Houston, J. E., Murphy, J., Adamson, G., Stringer, M., Shevlin, M., 2008. Childhood 
sexual abuse, early cannabis use, and psychosis: testing an interaction model based on 
the National Comorbidity Survey. Schizophrenia Bulletin 34, 580-585. 
 
Jaffee, S. R., Moffitt, T. E., Caspi, A., Fombonne, E., Poulton, R., Martin, J., 2002. 
Differences in early childhood risk factors for juvenile-onset and adult-onset depression. 





Kendler, K. S., Karkowski, L. M., Prescott, C. A., 1999. Causal relationship between 
stressful life events and the onset of major depression. American Journal of Psychiatry 
156, 837-841. 
 
Kendler K.S., Gardner C.O., 2010. Interpretation of interactions: guide for the perplexed. 
British Journal of Psychiatry 197(3), 170-171. 
 
Koenen, K. C., Moffitt, T. E., Poulton, R., Martin, J., Caspi, A., 2007. Early childhood 
factors associated with the development of post-traumatic stress disorder: results from 
a longitudinal birth cohort. Psychological Medicine 37, 181-192. 
 
Koenen, K. C., Moffitt, T. E., Roberts, A. L., Martin, L. T., Kubzansky, L., Harrington, H., 
Poulton, R., Caspi, A.,2009. Childhood IQ and adult mental disorders: a test of the 
cognitive reserve hypothesis. American Journal of Psychiatry 166, 50-57. 
 
Kremen, W. S., Seidman, L. J., Faraone, S. V., Tsuang, M. T., 2008. IQ decline in cross-
sectional studies of schizophrenia: Methodology and interpretation. Psychiatry Research 
158, 181-194. 
 
Kuh, D., Ben-Shlomo, Y., Lynch, J., Hallqvist, J., Power, C., 2003. Life course 
epidemiology. Journal of Epidemiology & Community Health 57, 778-783. 
 
Lederbogen F, Kirsch P, Haddad L, Streit F, Tost H, Schuch P, Wüst S, Pruessner JC, 
Rietschel M, Deuschle M, Meyer-Lindenberg A., 2011. City living and urban upbringing 
affect neural social stress processing in humans. Nature 474, 498-501 
 
Lichtenstein, P., Yip, B. H., Björk, C., Pawitan, Y., Cannon, T. D., Sullivan, P. F., Hultman, 
C.F.,2009. Common genetic determinants of schizophrenia and bipolar disorder in 





Luchsinger, J. A., Reitz, C., Honig, L. S., Tang, M. X., Shea, S., Mayeux, R., 2005. 
Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 65, 
545-551. 
 
Ludtke, O., Marsh, H. W., Robitzsch, A., Trautwein, U., Asparouhov, T.,  Muthen, B.,  
2008. The multilevel latent covariate model: a new, more reliable approach to  
group-level effects in contextual studies. Psychological Methods 13, 203-229. 
 
Lynch, J., Smith, G. D., 2005. A Life Course Approach to Chronic Disease Epidemiology. 
Annual Review of Public Health 26, 1-35. 
 
Lynch, J. W., Kaplan, G. A., Shema, S. J., 1997. Cumulative impact of sustained economic 
hardship on physical, cognitive, psychological, and social functioning. New England  
Journal of Medicine 337, 1889-1895. 
 
MacKinnon, D. P., 2008. Introduction to Statistical Mediation Analysis. Erlbaum, New  
Jersey. 
 
Martens, E., Pestman, W., de Boer A., Belitser, S.V., Klungel, O.H., 2006. Instrumental 
variables: applications and limitations. Epidemiology 17, 260-267.  
 
McArdle, J. J., Hamagami, F.,1992. Modeling incomplete longitudinal and  
cross- sectional data using latent growth structural models. Experimental Aging  
Research 18, 145-166. 
 





Melchior, M., Moffitt, T. E., Milne, B. J., Poulton, R., Caspi, A., 2007. Why do children 
from socioeconomically disadvantaged families suffer from poor health when they reach 
adulthood? A life-course study. American Journal of Epidemiology 166, 966-974. 
 
Murray, L., Fiori-Cowley, A., Hooper, R., Cooper, P., 1996. The impact of postnatal 
depression and associated adversity on early mother-infant interactions and later infant 
outcome. Child Development 67, 2512-2526. 
 
Painter, R. C., de Rooij, S. R., Bossuyt, P. M., Simmers, T. A., Osmond, C., Barker, D. J., 
Bleker, O.P., Roseboom, T.J.,2006. Early onset of coronary artery disease after prenatal 
exposure to the Dutch famine. The American Journal of Clinical Nutrition 84, 322-327. 
 
Palazidou, E., 2012. The neurobiology of depression. British Medical Bulletin 101, 127-
145. 
 
Pearl, J., 2000. Causality: Models, Reasoning, and Inference. New York: Cambridge 
University Press. 
 
Picken, A. L., Berry, K., Tarrier, N., Barrowclough, C., 2010. Traumatic events, 
posttraumatic stress disorder, attachment style, and working alliance in a sample of 
people with psychosis. Journal of Nervous and Mental Disorders 198, 775-778. 
 
Power, C., Manor, O., Matthews, S., 1999. The duration and timing of exposure: effects 
of socioeconomic environment on adult health. American Journal of Public Health 89, 
1059-1065. 
 
Power, C., Matthews, S., Manor, O., 1996. Inequalities in self rated health in the 1958 






Power, C., Elliott, J., 2006. Cohort profile: 1958 British birth cohort (National Child  
Development Study). International Journal of Epidemiology 35, 34-41. 
 
Rabe-Hesketh, S.,  Skrondal, A.,2008. Classical latent variable models for medical  
research. Statistical Methods in Medical Research 17, 5-32. 
 
Rantakallio, P., 1988. The longitudinal study of the Northern Finland birth cohort of  
1966. Paediatric and Perinatal Epidemiology 2, 59-88. 
 
Reichenberg, A., Caspi, A., Harrington, H., Houts, R., Keefe, R. S., Murray, R. M., Poulton, 
R., Moffitt, T.E., 2010. Static and dynamic cognitive deficits in childhood preceding adult 
schizophrenia: a 30-year study. American Journal of Psychiatry 167, 160-169. 
 
Seeman, M. V., 2010. Psychosis in women: Consider midlife medical and psychological 
triggers. Current Psychiatry 9, 64-76. 
 
Semple, D. M., McIntosh, A. M., Lawrie, S. M., 2005. Cannabis as a risk factor for 
psychosis: systematic review. Journal of Psychopharmacology 19, 187-194. 
 
Shanahan, M. J., Hofer, S.M., 2010. Molecular genetics, aging, and the life course: 
sensitive periods, accumulation, and pathways models. Handbook of Aging and the 
Social Sciences, edited by Robert H. Binstock & Linda George, Elsevier. 
 
Silva, P. A., 1990. The Dunedin Multidisciplinary Health and Development Study: a 15  
year longitudinal study. Paediatric and Perinatal Epidemiology 4, 76-107. 
 
Sisk, C. L., Zehr, J. L., 2005. Pubertal hormones organize the adolescent brain and 





Smith, G. D., Hart, C., Blane, D., Gillis, C., Hawthorne, V., 1997. Lifetime socioeconomic 
position and mortality: prospective observational study. British Medical Journal  314, 
547-552. 
 
Van den Berg, B. J., Christianson, R. E., Oechsli, F. W., 1988. The California Child  
Health and Development Studies of the School of Public Health, University of  
California at Berkeley. Paediatric and Perinatal Epidemiology 2, 265-282. 
 
Wadsworth, M. E., 1987. Follow-up of the first national birth cohort: findings from  
the Medical Research Council National Survey of Health and Development.  
Paediatrin and Perinatal Epidemiology 1, 95-117. 
 
Wamala, S. P., Lynch, J., Kaplan, G. A., 2001. Women's exposure to early and later life 
socioeconomic disadvantage and coronary heart disease risk: the Stockholm Female 
Coronary Risk Study. International Journal of Epidemiology 30, 275-284. 
 
Weissman, M.M., Brown, A.S., Talati, A, 2011. Translational epidemiology in psychiatry: 
Linking population to clinical and basic sciences. Archives of General Psychiatry 68, 600-
608.   
 
Whitford, T. J., Rennie, C. J., Grieve, S. M., Clark, C. R., Gordon, E., Williams, L. M.,  2007. 
Brain maturation in adolescence: Concurrent changes in neuroanatomy and 
neurophysiology. Human Brain Mapping 28, 228-237. 
 
Woodberry, K. A., Giuliano, A. J., & Seidman, L. J., 2008. Premorbid IQ in Schizophrenia: 





Woodward, L. J., Fergusson, D. M., 2001. Life course outcomes of young people with 
anxiety disorders in adolescence. Journal of the American Academy of Child and 















Fig. 1 Critical periods of risk exposure and cumulative interactions of risk factors for psychotic illness: an illustrative example of 





Fig 2. Differences in the developmental course of cognitive functions from childhood 



















2   Life course approach for bipolar disorder 
 
2.1 Introduction  
In this chapter the concept of Bipolar Disorder (BD) is introduced by examining its 
associated clinical features. Subsequently, the importance of disentangling the 
mechanisms leading to BD are highlighted by reviewing studies on the increased 
personal and societal burden associated with BD. Moreover, the evidence on prevalence 
rates for BD in the general population and in youths as well as the comorbidities with 
other psychiatric disorders is reviewed. The chapter concludes by emphasizing the 
importance of life course approaches for the study of BD in relation to the identification 
of a valid prodromal phase and conversion to BD. The objectives and hypotheses of each 
study are formulated in the corresponding Chapters 4-6. 
 
 2.1.1 Clinical Features  
BD is characterized by profound and pathological changes in mood. It presents with 
recurrent episodes of depression interspersed with periods of mania and is associated 
with significant psychosocial morbidity and mortality (Baldessarini and Tondo, 2003). 
In its classic form, or BD type 1 (BD-I), the illness is defined by the presence of at least 
one manic episode (World Health Organisation(WHO), 1993; APA, 1994). The spectrum 
of BD disorders also includes BD type II (BD-II), and cyclothymia. In both, manic 
symptoms are milder and of shorter duration. In contrast, depressive symptoms are 
common across all subtypes of BD and overlap with the presentation of unipolar or 
major depressive disorder (in which the patient never has mania or hypomania).   
 
 2.1.2 Personal and Societal Burden   
BD is one of the leading causes of disability worldwide (WHO, 2008). This also applies to 
Europe in general (Fajutrao et al. 2009). In the UK the direct (e.g. the unit resource 




attributable to BD are almost 2 billion pounds per year (Das Gupta et al., 2002).  These 
costs remain high as in 2009/2010 the annual cost of BD to the National Health Service 
(NHS) reached £342 million (Young et al., 2011). Estimates of the total costs of BD in the 
USA may be even higher exceeding 45.2 billion dollars (Wyatt & Henter, 1995). 
 
The negative impact of BD is accentuated by its early onset with the majority of patients 
presenting between 16-35 years of age (Perlis et al., 2004; Berk et al., 2007a; 
Merikangas et al, 2011). Additionally suicide is a major concern as standardized 
mortality ratios for suicide in BD range between 12.3 and 22.4 (Wunderlich et al., 1998; 
Ősby et al., 2001).  BD can also lead to profound disruptions in work and social 
functioning, including high unemployment rates and relationship breakdowns (Mitchell 
& Malhi, 2004; Morgan et al., 2005; Kessler et al., 2006; Ruggero et al., 2007; 
Zimmerman et al., 2010). 
  
2.2 Prevalence of BD 
 2.2.1 Lifetime Prevalence of BD 
The reported prevalence rates vary greatly. Akiskal et al. (2000) summarized important 
methodological factors which can at least partially account for this variability. These 
include the breadth of the criteria used to define BD, the type of diagnostic instruments, 
the experience and background of the interviewer (lay vs. clinical), the population 
studied , sample size, the number of observations (single vs. repeated), informant 
(interview of patients vs. relatives) and the timing of the interview.  
 
Studies that use a narrow definition for syndromal BD-I report low lifetime prevalence 
rates. Kessler et al. (1994) reported  a rate of 1.6% in a representative US national 
sample of 8,098 participating in the National Comorbidity Survey (NCS) and Regier at al. 
(1988) reported 1.2% lifetime prevalence in 18,571 subjects participating in the National 




 Higher rates have been reported when the definition of BD was broadened to include 
bipolar spectrum disorders (i.e. brief hypomania and cyclothymia) and subthreshold 
hypomania lasting less than 4 days. Angst et al. (1998) applied these criteria to the 
Zurich cohort and found a cumulative prevalence rate over four interviews of 5.5 % 
(hypo)mania for participants up to age 35 years. A similar rate of 5.1 % for bipolar 
spectrum disorders was reported in a Hungarian adult population sample (18-64 years) 
(Szádóczky et al., 1998). 
 
Recent epidemiological studies have commonly used the Composite International 
Diagnostic Interview (CIDI), a structured lay-administered diagnostic interview, to 
diagnose BD based on DSM-IV and ICD-10 criteria (Kessler et al. 2005; Merikangas et al. 
2007) and to estimate the prevalence of broader definitions of  BD that include 
recurrent hypomania without a major depressive episode or subthreshold hypomania 
(Merikangas et al., 2007).  In a nationally representative sample of 9,282 US adult 
members of the National Comorbidity Survey Replication (NCS-R) the lifetime 
prevalence rate for syndromal BD was reported to be 2.6% with a 12-month prevalence 
of 2.6% in 2005 (Kessler et al. 2005) and 1.4% in 2007 (Merikangas et al., 2007). Lifetime 
prevalence of BD was increased to 4.5% when considering subthreshold expressions 
(Merikangas et al., 2007).  
 
 2.2.2. Prevalence of BD in Youth  
Typical lifetime prevalence rates of BD in younger populations range from 1.0% 
(Lewinsohn et al., 2000) to 1.8% (Wittchen et al., 1998) and 6 to 12 month prevalence 
range from 0.4% (Verhulst et al., 1997) to 2.5% (Benjet et al., 2009).  A recent meta-
analysis of 12 studies examining the prevalence of BD in community epidemiological 
samples of youths aged 7 and 21 years reported an overall rate of 1.8% (95%CI 1.1%-
3.0%) (Van Meter et al., 2011). The rates of bipolar spectrum disorders in the studies 
included in this meta-analysis ranged from 0.0% (Lynch et al., 2006) to 6.3% (Kessler et 





 The most recent findings stem from the NCSR-Adolescent Supplement (NCSR-A) 
(Merikangas et al., 2010; Kessler et al., 2012). The sample of the NCS-A included 6,483 
adolescents aged between 13 and 17 years. The reported lifetime prevalence rate for 
BD was 2.9% (95%CI 2.3%-3.5%) (Merikangas et al., 2010). For the 12-month and 30- day 
prevalence periods the rates were 2.1% (95% CI 1.7%-2.5%) and 0.7% (95% CI 0.5%-
0.9%) respectively (Kessler et al., 2012).  
 
2.3 Bipolar Disorder Across the Life-Span 
 2.3.1 Age-Dependent Manifestations of BD 
BD characteristically begins in adolescence or early adulthood with the modal age of 
onset between 16 and 20 years (Roy-Byrne et al., 2007; Mesman et al., 2013) that does 
not differ between sexes (Kawa et al., 2005).  While BD can be diagnosed in children and 
adolescents (early onset BD) (Axelson et al., 2006; Birmaher et al., 2006a) the symptoms  
may be atypical with mixed and dysphoric features being more prominent than in adults 
(Birmaher et al., 2006b; Berk et al., 2007b). Cases of early onset BD are often comorbid 
with other common childhood disorders (Geller et al., 2002; Youngstrom et al., 2005; 
Carlson and Meyer, 2006). 
 
Therefore, the task of diagnosing youths with BD is challenging. Berk et al. (2007b) 
outlined a number of reasons that contribute to the complexity of ascertaining BD in 
younger patients. The main ones included a) patients denial or misattribution of 
symptoms of mania; b) mild mania can be pleasant and may not necessarily be 
considered as symptomatic of an illness; c) phenomenological overlap with agitated 
depression; d) disruptive symptoms and irritability being interpreted as an abnormal 
personality; e) frequent misdiagnosis of BD as Attention Deficit Hyperactivity 
Disorder (ADHD); f) presence of multiple comorbid conditions; and g) psychotic 





In addressing these issues several studies have tried to define the symptomatic 
profile and variation of BD from 5 years of age onwards using factor analytic 
techniques (Youngstrom 2002; Frazier 2007; Papolos 2007; Youngstrom 2008; Topor 
2013). The number of factors extracted ranged from 1 (Youngstrom et al. 2002) to 
10 (Papolos et al., 2007). The difference in the number of factors can be accounted 
for by the different instruments used, potential age differences in the presentation 
of manic symptoms and the age of onset relative to the age of assessment. 
Two studies, Youngstrom et al. (2002) and Frazier et al., (2007), have attempted to 
address the issue of age differences in the presentation of manic symptoms by 
comparing the factor structure of manic symptomatology in children to that of 
adolescents. Both studies report that a single factor-solution described both age 
groups suggesting a similar manifestation of bipolar symptomatology in children and 
adolescents. 
Additionally, one study (Topor et al., 2013) has examined the factor structure of manic 
symptomatology relative to the age of symptoms onset and current age. In this study, 
347 youths with childhood or adolescence onset BD were assessed using the  Schedule 
of Affective Disorders and Schizophrenia for School-Age Children (K-SADS) Mania Rating 
Scale (MRS). The results suggest that a 2-factor structure, termed “activated/pleasure 
seeking” and “labile/disorganized/psychotic” fitted the data best for children with 
childhood onset BD and for adolescents with adolescence-onset BD.  Symptoms for 
adolescents with childhood onset BD were best described by a single factor 
encompassing both “activated/pleasure-seeking” and “disorganized” symptoms but not 
labile behavior. The authors suggest that the reduced factor structure observed in this 
group of adolescents might be an artifact of recall errors resulting from longer time 
period between symptom onset and assessment (Topor et al., 2013). Although 
plausible, these findings are yet to be expanded in longitudinal settings in order to 
assess the temporal stability of manic manifestations. In Chapter 4 (Child Behavior 




scale for bipolar disorder) I address this issue by examining the underlying (i.e. latent) 
structure of manic symptoms from childhood (11 years) to adolescence (16 years) using 
a newly developed scale, the CBCL-MS.           
 
 2.3.2 Illness Severity in relation to Age of Onset  
Perlis et al. (2009) suggested that early identification and diagnosis may allow for earlier 
treatment that may improve long-term outcomes. However, the delay between onset 
and diagnosis of BD is typically between 5-10 years (Lish et al., 1994; Baethge et al., 
2003; Hirschfeld et al 2003; Berk et al, 2007b).   
 
Early onset of BD is a predictor of worse clinical outcomes compared to adult onset 
cases as it is associated with higher number of comorbidities, more suicide attempts and 
increased illness severity in terms of number and duration of episodes (McElroy et al., 
2001; Carlson et al., 2002; Perlis et al., 2004; Larsson et al., 2010; Post et al., 2010). In a 
key study using data from seven international centers, Baldessarini et al. (2012) not only 
confirmed that early onset BD was associated with worse clinical and but also 
demonstrated greater impairment in functional outcomes including employment, living 
conditions, marital status, and education.  
 
However, the effect of early onset on outcome may be mediated by factors not directly 
related to increased illness severity such as family adversity and cumulative psychosocial 
disadvantage caused by the early disruption in education and social role attainment 
(Levy et al., 2012). In chapter 5 and 6 (Chapter 5. Alarm Symptoms in the early 
diagnosis of bipolar disorder: a population based cohort study; Chapter 6. Trajectories 
to Bipolar Disorder from childhood to adulthood), I examine the effect of multiple 
sociocognitive and familial risk factors on trajectories into BD. This information can shed 
light on mechanisms leading to overt disease expression and has the potential to 





 2.3.3 Psychiatric Comorbidities   
 Adult patients with BD present with high rates of comorbid Axis I disorders particularly 
substance use, anxiety disorders (Chen et al., 1995a; Chen et al., 1995b; Kessler et al., 
1996; Szadosczky et al., 1998) and eating disorders (Kruger et al., 1996; McElroy et al., 
2001). McElroy et al. (2001) examined psychiatric comorbidities in 288 adult patients 
with BD and found that 42% had comorbid anxiety and substance use disorders and 5% 
had eating disorders. In the NCSR the comorbidity rates were 5.7% for anxiety disorders 
and 39.1% for substance use disorders (Merikangas et al., 2007). Generally, Axis I 
psychiatric comorbidities are associated with earlier age of onset of BD, higher rates of 
suicidality, poorer overall outcome and less favorable response to lithium (McElroy, 
2001; Post et al., 2010). 
 
High rates of comorbid psychiatric disorders have also been reported in early onset BD 
although the rates vary depending on sample selection (clinical versus community 
samples), method of diagnostic ascertainment (routine clinical interviews, structured 
diagnostic interviews, type of diagnostic instrument, availability of informants, clinical 
experience of the interviewer) and diagnostic classification system (Pavuluri et al., 
2005). For example, because disorders are hierarchically classified in the DSM-IV a 
diagnosis of Oppositional Defiant Disorder (ODD) cannot be made in the presence of BD. 
Current estimates suggest that in early onset BD comorbidity rates are between 46.4% 
and 75% for ODD, 5.6% and 37% for conduct disorder, 12.5% and 56% for anxiety 
disorders, and 0% and 40% for substance abuse disorders (Pavuluri et al., 2005). 
However, the most common comorbid condition is ADHD; up to 85% of youth with BD 
may also have ADHD while up to 25% of those with ADHD may also suffer from BD 
(Singh et al. 2006). The type of comorbidities depends largely on the age of onset; 
Findling et al. (2001) and Wilens et al. (2004) have shown that young children with BD 
are more likely to have comorbid ADHD while older adolescents are more likely to have 





The high rates of comorbidity may be explained by shared genetic vulnerability as has 
been suggested for substance use (Lin et al., 2006), anxiety disorders (Erhard et al., 
2007; Goes et al., 2012) and ADHD (Faraone et al., 1997; Neslihan Inal-Eiroglu et al., 
2008).  BD and ADHD may also share neurobiological correlates (Zepf, 2009; Passarotti 
et al., 2010a; Passarotti et al., 2010b; Skirrow et al., 2012). 
 
 2.3.4 Differential Diagnosis of BD 
In adult patients the main difficulty lies in the differential diagnoses of BD from major 
depressive disorder (MDD). This is because depressive symptoms tend to dominate the 
clinical presentation of BD both at onset and during the long-term course of the disorder 
(Perugi et al., 2000; Judd et al., 2002). Additionally, BD is associated with high rates 
(between 60-80%) of psychotic symptoms during mood episodes; especially in younger 
patients this may result in difficulties in differentiating BD from schizophrenia (Keck et 
al., 2003; Coryell et al., 2001).  
 
In youth with BD the main challenge is the differentiation of BD from other disorder of 
disruptive behaviour, particularly ADHD. Two main distinguishing features have been 
proposed. Geller et al. (2002) emphasized the importance of elevated mood, 
grandiosity, flight of ideas, hypersexuality and decreased need for sleep for a diagnosis 
of mania. Others consider episodicity as important in differentiating between BD from 
other disruptive disorders such as ADHD (Carlson, 1998; Asherson et al., 2007; 
Leibenluft and Rich, 2008; Youngstrom et al.,2010). Some have challenged this based on 
findings that children and adolescents with BD tend to experience more chronic 
symptoms and clear episodes may not be easy to identify (Biederman et al., 2004). 
 
Psychotic symptoms, particularly mood-incongruent delusions and hallucinations and 
thought disorder can lead to misdiagnosing BD as schizophrenia in as many as 50% of 
early onset BD cases (Carlson, 1990; Werry et al., 1991). Finally, the activation and 




and emotional lability associated with internalising and externalising conditions, 
including ODD, conduct, anxiety, depressive and borderline personality disorders 
(Leibenluft et al., 2003; Cumyn et al., 2009; Stringaris and Goodman, 2009; Skirrow et 
al., 2012) can also be mistaken for mania. In Chapter 4 (Child Behavior Checklist- Mania 
Scale (CBCL-MS): Development and validation of a population-based scale for bipolar 
disorder), I examine the ability of behavioural assessments of different symptom 
dimensions of BD in youths to distinguish between BD and other diagnostic categories, 
particularly MDD, general anxiety disorder and ADHD. 
 
   2.3.5 The concept of prodrome in bipolar Disorder 
Results from retrospective studies suggest that about a third of patients report 
difficulties in mood regulation before the full blown onset of BD (Lish et al, 1994; 
Egeland et al, 2003; Hirschfeld et al, 2003; Berk et al, 2007a; Corell et al, 2007; Mantere 
et al., 2008). This evidence suggests that prior to their first manic episode patients may 
experience prodromal symptoms for an average of 2 years, most commonly mood 
lability, excitability, low energy and mood and insomnia with variable impairment in 
functional roles (Egeland et al, 2003; Shaw et al, 2005; Corell et al, 2007; Mantere et al., 
2008; Skjelstad et al., 2010). Although these studies provide support for the presence of 
a prodrome in BD, the evidence derives mostly from affected offspring of BD patients 
(Hillegers et al. 2005; Duffy et al, 2007) and from patients with childhood onset BD 
(Correll et al, 2007; Birmaher et al, 2009; Birmaher 2010; Luby and Navsaria 2010).  This 
raises concerns about generalisability since approximately half of BD patients do not 
have a positive family history of the disorder (Tijssen et al, 2010a; Baldessarini et al., 
2012) and onset in childhood is rare and therefore atypical (Larsson et al 2010). 
  
Additionally, the sensitivity and specificity of these putative prodromal symptoms has 
yet to be determined.  This issue is of particular importance since putative signs of 




are common in adolescence and young adulthood (Tijssen et al, 2010b), a period that 
coincides with the peak incidence years for BD (Perlis et al, 2004; Berk et al, 2007a). 
 Finally, all studies in this area have been symptom based, in other words they have 
focused on score values for one or more dimensions of psychopathology. It is becoming 
increasingly apparent that symptom-based approaches are not helpful as symptom 
dimensions are not pathognomonic (Krabbendam et al, 2004). Therefore the success of 
diagnostic and intervention strategies is based on our ability to move to person-centred 
approaches and define the characteristics of groups of individuals at risk for BD in order 
to characterise their mental health needs and help seeking behaviour for use in future 
strategies for early identification and prevention. In Chapter 6 (Trajectories to Bipolar 
Disorder from childhood to adulthood) I use a person centered approach within a 
longitudinal cohort study design to identify qualitative differences and transition rates 
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The methodological approach followed in each of the studies comprising Chapters 4-6 
(Chapter 4.Child Behavior Checklist- Mania Scale (CBCL-MS): Development and 
validation of a population-based scale for bipolar disorder; Chapter 5. Alarm 
Symptoms in the early diagnosis of bipolar disorder: a population based cohort study 
and Chapter 6. Trajectories to Bipolar Disorder from childhood to adulthood) are 
described in the corresponding chapters. The focus of this chapter is to introduce and 
describe the Tracking Individuals Lives Survey (TRAILS), a prospective cohort study which 
commenced in 2001 in Groningen, Holland and provided the data used to address the 
objectives of this thesis. Therefore, this chapter will commence by providing an 
overview of the organization of TRAILS and a description of the relevant ethical approval 
obtained.  Next, the analytic cohort will be described and the chapter will conclude by a 
description of the instruments used in the studies. 
 
3.2 Overview of the Tracking Individuals Lives Survey (TRAILS) 
TRAILS (www.trails.nl/en/) is an ongoing prospective multidisciplinary cohort study 
which commenced in 2001 and acquired biennial assessments of sociocognitive, familial 
and  psychological characteristics of 2,230 youngsters.  The first assessment wave (T1) 
took place during 2000-2001, the second (T2) during 2003-2004, the third during 2005-
2007 (T3) and the fourth during 2008-2010 (T4). Currently, the fifth wave (T5) is being 
finalized. Data from T5 were not included in the analyses of the studies presented in this 
thesis as it has not yet been completed.  
 
The primary aim of TRAILS was to study the mental, social and physical development of 




than 170 publications using data collected by TRAILS had been published in international 
peer-reviewed journals. TRAILS, therefore, takes aim to disseminate gained knowledge 
among international professional colleagues, professionals in mental health and 
education, policy makers and other stakeholders. 
  
The data collected by TRAILS cover a broad range of domains including a) mental 
health/general adjustment, b) physical health and development, c) family 
characteristics, d) personality and social development, e) cognitive data f) biological 
data and others. These were obtained from multiple sources including self-reports, 
parents, siblings, teachers and peers.  
 
TRAILS is managed by the University Medical Centre of Groningen (UMCG) and the 
Erasmus Medical Center of Rotterdam. Other participating universities include 
the Radboud University Nijmegen Medical Centre and Utrecht University. The principle 
investigators are Prof. A.J. Oldehinkel of the Department of Psychiatry of the University 
Medical Center Groningen, and Prof. F.C. Verhulst of the Department of Child and 
Adolescent Psychiatry of the Erasmus University Medical Center Rotterdam. The 
research group of TRAILS consists of a multidisciplinary team of members of various 
departments, including (child and adolescent) psychiatry, epidemiology, biostatistics, 
social sciences, health sciences, kinesiology, pediatrics and respiratory disease across 
several universities throughout The Netherlands. Other key members of TRAILS include 
the additional head investigators  Dr. C.A. (Catharina) Hartman and Prof. dr. J. 
(Hans) Ormel of the University Center for Psychiatry, UMCG. 
 
TRAILS is financially supported by grants from The Dutch Organisation for Health 
Research and Development (ZonMw), The Dutch Organization for Scientific Research 
and the Department of Justice. Additional grants have been received by Sophia 
Stichting of the Erasmus Medical Center (WODC), the European Science Foundation 




Infrastructure BBMRI-NL (CP 32), the participating universities, and the Accare Center 
for Child and Adolescent Psychiatry. 
 
3.3 Ethics 
TRAILS was approved by the national ethical committee ‘Centrale Commissie 
Mensgebonden Onderzoek’ and the Dutch Central Committee on Research Involving 
Human Subjects (CCMO). Permission for me to use anonymised data from the survey 
was granted by the study management committee. All data were anonymised according 
to the UMCG research code guidelines 
(http://www.rug.nl/umcg/research/general/research-code) and the research office TNS 
NIPO [http://www.tns-nipo.com/] protocols. 
 
3.4 The analytic cohort 
The sampling procedure followed by TRAILS is described in three studies (de Winter et 
al., 2005; Huisman, et al., 2008; Ormel et al., 2012) and is summarized in Figure 3.1. 
Briefly, it consisted of two stages. During the first one, five municipalities in the North of 
Netherlands were contacted to obtain demographic details of all children born between 
1 October 1989 and 30 September 1991; subsequently, 135 schools were identified and 
invited to participate in the study (N=3,483). 13 schools (338 children) refused to 
participate. During the second sampling stage, the parents of the identified children 
were informed about the nature and objectives of the study and were invited to 
participate. Of the 3,145, 210 were unable to participate for various reasons including 
severe mental retardation and non-Dutch speaking parents or parent surrogates, thus 
resulting in a baseline sample of 2,230 participants with a mean age of 11.1 years 








Figure 3.1 Sampling Procedures of TRAILS 
 
 








The attrition rate during the subsequent waves of assessment has remained low and is 
summarized in Figure 3.2. 2,149 subjects participated in the second wave (96% of 
baseline sample; mean age M= 13.55, SD= 0.54), 1,816 in the third wave of assessment 
(81.4% of baseline sample; mean age M=16.27, SD= 0.73) and 1,881 in the fourth wave 
of assessment (84.3% of baseline sample; mean age M=19.08, SD= 0.60). Attrition at 
follow-ups was slightly higher in males and participants of nonwestern ethnicity, as well 
as in participants with divorced parents, low socioeconomic status and low IQ and 
academic achievement. Sexes are equally represented within the sample; specifically, 
the percentage of females was 50.8%, 51.00%, 52.3% and 54.6% for the four waves of 
data collection, respectively. The fifth wave of assessment remains ongoing and is 
expected to finish by the end of 2013.  
 
Figure 3.2 Attrition Rates in TRAILS 
 




3.5 Instruments  
 3.5.1 Outcome Measures 
  3.5.1.1 The World Health Organization (WHO) Composite  International   
 Diagnostic Interview (CIDI) 
TRAILS investigators used the WHO-CIDI version 3.0 [Computer Assisted Interview (CAPI) 
version 20)] (http://www.hcp.med.harvard.edu/wmhcidi/) to ascertain lifetime 
psychiatric diagnoses based on ICD-10 and DSM-IV criteria during the fourth assessment 
wave (T4). The WHO-CIDI is a comprehensive, fully structured interview designed to be 
used by lay interviewers for the assessment of mental disorders as defined by the ICD-
10 and DSM-IV diagnostic criteria and it allows investigators to measure the prevalence, 
severity, and burden of mental disorders as well as assess service use, the use of 
medications in treating these disorders and the barriers to treatment. The diagnostic 
section of the interview is based on the World Health Organization's Composite 
International Diagnostic Interview (WHO CIDI, 1990).  
 
Wittchen (1994) in a review of studies assessing the reliability and validity of the CIDI 
reports that test retest agreement ranged from 81% (persistent pain disorder) to 97% 
(panic disorder) and interrater kappa coefficient from .67 (somatization) to .87 (major 
depression). For Bipolar Disorder (BD)-I, the WHO-CIDI has high test-retest reliability 
(87%) as well as excellent concordance rates (AUC=.99) with blindly administered clinical 
re-interviews using the non-patient version of the Structured Clinical Interview for DSM-
IV (SCID) (Haro et al., 2006; Kessler et al., 2006). Additionally, excellent concordance 
rates with the DSM-IV (SCID) disorders have been reported for lifetime bipolar spectrum 
disorders (BDII and Hypomania) (Kessler et al., 2006). 
 
  3.5.1.2 CBCL 
TRAILS participants were administered the Child Behaviour Checklist (CBCL) 6-18 
(Achenabch & Resporla, 2001), which is a revision of the CBCL 4-18 (T.M. Achenbach, 




CBCL 6-18 is a parent- or parent surrogate- report checklist of child behaviour problems 
including various aspects of psychopathology in childhood and adolescence occurring 
during a specified period of time (e.g. the last 6 months) consisting of 118 items scored 
from 0 to 2 (0= not true, 1= somewhat or sometimes true, and 2= very true or often 
true) on the basis of the preceding 6 months (T.M. Achenbach, 1991). According to the 
results of factor analyses, scores can be summarized in eight syndrome scales or two 
broad groupings of syndromes which provide clinically useful associations with different 
diagnostic groups (Edelbrock & Costello, 1988; Eiraldi, Power, Karustis, & Goldstein, 
2000; Kasius, Ferdinand, van den Berg, & Verhulst, 1997); these include a) ‘Internalising 
Behaviours’ encompassing the  ‘Withdrawn’, ‘Somatic Complaints’ and 
‘Anxious/Depressed’ scales; and b) Externalising Behaviours  encompassing the 
‘Delinquent Behaviour’ and ‘Aggressive Behaviour’ scales. The remaining scales include 
‘Social Problems’, ‘Thought Problems’ and ‘Attention Problems’. Items that are not 
accurately classified in any of these scales are summarized under ‘Other Problems’. 
 
Besides scoring profiles reflecting patterns of co-occuring problems, CBCL is an 
assessment instrument which can view children’s problems from the perspectives of 
formal diagnostic systems, e.g. the DSM-IV. (T. M. Achenbach & Rescorla, 2001).  
Achenbach et al. (2001) have grouped items into the following DSM-oriented scales: 
Affective Problems, Anxiety Problems, Somatic Problems, Attention 
Deficit/Hyperactivity Problems, Conduct Problems and Oppositional/Defiant Problems. 
In contrast to the factor analytic methods used to develop the Syndrom Scales, the DSM 
oriented scales were constructed through agreement in experts’ ratings of the 
preexisting items’ consistency with DSM-IV diagnostic criteria. These six scales present 
with high test-retest reliability and their Cronbach’s alpha range from .71 for the 
Somatic Problems items to .89 for the Conduct Problems items (Nakamura, Ebesutani, 
Bernstein, & Chorpita, 2009). These instruments provide highly efficient ways to screen 
for several disorders including ADHD (Derks, et al., 2006), major depressive disorder and 





The DSM-oriented scales of the CBCL have also been cross-validated by a Semi-
structured Clinical Interview for Children and Adolescents (SCICA)(McConaughy & 
Achenbach, 2001). Compared to a national sample of children rated by their teachers, 
clinically meaningful thresholds for a deviation from age-and sex-matched healthy 
children are standardized T scores ranging from 65 (93rd Percentile) to 69 (97th 
Percentile) which are considered to be in the borderline clinical range; T scores > 70 
represent the clinical range (T. M. Achenbach & Rescorla, 2001). 
 
The CBCL has been translated in over 90 languages including Dutch. In a study on 2,339 
Dutch youths aged 4 to 18 years, results of factor analyses suggested that the syndrome 
scales were very similar in item composition to the ones derived originally by Achenbach 
(1991). Additionally, cross-national correlations ranged from .82 for the Social Problems 
syndrome to .99 for the Somatic Complaints and Anxious/Depressed syndromes. In the 
TRAILS sample items of the CBCL had moderate to high internal consistency at all three 
assessment waves. Specifically, Cronbach’s alpha values ranged from 0.64 to 0.84, from 
0.64 to 0.82, and from 0.65 to 0.82 for the DSM-oriented scales at T1, T2 and T3 
respectively.  
 
 3.5.2 Additional Measures 
   3.5.2.1 Family Psychiatric Morbidity 
At T1, family psychiatric morbidity was assessed using the TRAILS Family History 
Interview which includes parental self-reports of a lifetime history of psychiatric 
disorders. For this interview, parents were presented with a description of the main 
DSM-IV characteristics of each disorder, followed by a series of questions assessing 
lifetime occurrence, the impact of the symptoms, the professional treatment received 
and medication use when applicable. Parents were then assigned one of the following 
categories: 0= (probably) never had an episode, 1= (probably) yes, or 2= yes and 




constructed as the pattern of associations between parental disorders and offspring 
psychopathology was similar for fathers and mothers despite the low correlation 
between maternal and paternal rates of occurrence of disorders (<0.20). 
 
In total, 42% of children had at least one parent with a psychiatric disorder.  The rates of 
reported paternal and maternal history of mental disorders in the TRAILS dataset were 
as follows: bipolar disorder (3.5% and 5.8%), major depressive disorder (16% and 27%), 
any anxiety disorder (5.3% and 15.1%), schizophrenia and spectrum disorders (1.9% and 
2.1%) and substance abuse (including drugs and alcohol) (6.4% and 2.1%). With the 
exception of major depressive disorder these prevalence rates compare to lifetime 
prevalence rates reported in other Dutch longitudinal cohort studies, e.g. the 
Netherlands Mental Health Survey and Incidence Study (NEMESIS) (Bijl et al., 1998). 
 
  3.5.2.2 Socioeconomic Status 
Socioeconomic status (SES) at age 11 (T1) was measured using a composite index of five 
indicators:  maternal and paternal education, family income and maternal and paternal 
occupation assessed by the International Standard Classification of Occupation 
(Ganzeboom & Treiman, 1996). A composite index of SES was constructed by averaging 
the five indicators upon standardization. This index captured 61.2% of the variance in 
the five items and presented with high internal consistency (Cronbach’s a=0.84). Missing 
values in cases such as single-parent families were accounted for in the averaging of the 
standardized items. Overall, 48.6% of TRAILS participants had middle SES, followed by 
24.8% and 24.7% with low and high SES respectively.  
  
  3.5.2.3 Family Functioning 
Family functioning at age 11 (T1) was measured using the General Functioning Subscale 
of the McMaster Family Assessment Device (FAD-GFS) (Epstein et al., 1983). The FAD-
GFS is a 12-item scale designed to be completed by family members and assesses overall 




total score is then calculated from the valid summed item scores and divided by 12 with 
scores of 2 or above indicating problematic family functioning. 
 
The FAD-GFS assesses six dimensions of family functioning; communications, problem 
solving, affective responsiveness, affective involvement, roles and behaviour control. In 
the TRAILS sample the scale presented with high internal consistency (Cronbach’s 
alpha=0.84). 
 
  3.5.2.4 Cognition 
An estimate of intellectual ability at age 11 (T1) was obtained following standardized 
administration of the Vocabulary and the Block Design subtests of the Wechsler 
Intelligence Scale for Children-Revised (WISC-R) (Wechsler, 1974). These two subtests 
were used as a proxy IQ score as they correlate highly with scores on the full test (r= 
0.90) (Sattler, 1982). A composite measure was calculated from the two subtests using 
the age-normalized standard scores. The IQ scores of the sample ranged from 45 to 149 
and had a mean value of 97 (M=97.19, SD=15.00). 
 
 
3.6 Missing Data 
Missing data have been kept low for most variables included in the analyses. For mental 
health dimensions and CBCL data the percentage of missing data ranged between 6% -
31% and 8%-22% respectively. Two per cent of the data were missing for SES, and 2-3% 
were missing for lifetime parental psychopathology. For data that could be assumed to 
be Missing At Random (MAR) or Completely At Random (MCAR) we used listwise 
deletion for cross-sectional assessments. For the structural equation models fitted using 
MPlus 6.0 and 7.0 (www.statmodel.com)  in Chapters 5 and 6, I used  the full 
information maximum likelihood (FIML) estimation approach, which has been shown to 
produce unbiased parameter estimates and standard errors under the MAR and MCAR 




imputations to minimize loss of statistical power and risk of bias using the SPSS IBM 
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Context: Early identification of Bipolar Disorder (BD) remains poor despite the high 
levels of disability associated with the disorder.       
Objective: We developed and evaluated a new DSM orientated scale for the 
identification of young people at risk for BD based on the Child Behavior Checklist 
(CBCL) and compared its performance against the CBCL-Pediatric Bipolar Disorder (CBCL-
PBD) and the CBCL-Externalizing Scale, the two most widely used scales. 
Methods: The new scale, CBCL-Mania Scale (CBCL-MS), comprises 19 CBCL items that 
directly correspond to operational criteria for mania.  We tested the reliability, 
longitudinal stability and diagnostic accuracy of the CBCL-MS on data from the TRacking 
Adolescents’ Individual Lives Survey (TRAILS), a prospective epidemiological cohort 
study of 2230 Dutch youths assessed with the CBCL at ages 11, 13 and 16. At age 19 
lifetime psychiatric diagnoses were ascertained with the Composite International 
Diagnostic Interview. We compared the predictive ability of the CBCL-MS against the 
CBCL-Externalising Scale and the CBCL-PBD in the TRAILS sample. 
Results: The CBCL-MS had high internal consistency and satisfactory accuracy (area 
under the curve= 0.64) in this general population sample. Principal Component 
Analyses, followed by parallel analyses and confirmatory factor analyses,  identified four 
factors corresponding to distractibility/disinhibition, psychosis, increased libido and 
disrupted sleep. This factor structure remained stable across all assessment ages.  
Logistic regression analyses showed that the CBCL-MS had significantly higher predictive 
ability than both the other scales.  
Conclusions: Our data demonstrate that the CBCL-MS is a promising screening 
instrument for BD. The factor structure of the CBCL-MS showed remarkable temporal 
stability between late childhood and early adulthood suggesting that it maps on to 





Bipolar Disorder (BD) is a complex mental disorder affecting between 0.1% and 4.4% 
of the general population [1]. BD is the sixth leading cause of disability worldwide 
particularly amongst adolescents and young adults [2]. This is partly due to the typically 
early onset of BD with the majority of patients presenting between 19-25 years of age 
[1,3]. More important however is the failure in recognizing and treating BD particularly 
in the early stages of the disorder.  The typical delay between onset and diagnosis is 5-
10 years [4-6] and is associated with greater clinical severity, increased psychosocial 
morbidity and higher treatment costs [7-9]. Although mania is the diagnostic hallmark of 
BD [10, 11] the differential diagnosis from Major Depressive Disorder (MDD) is often 
difficult as BD is commonly dominated by depressive symptoms [12,13]. Furthermore, 
BD is also associated with high rates (between 60-80%) of psychotic symptoms during 
mood episodes [14,15]. High rates of psychotic symptoms have also been reported in 
young patients and confirm their role as a key symptom dimension of BD in adolescence 
[16, 17]. Additional diagnostic challenges arise from the symptomatic overlap between 
BD and Attention Deficit Hyperactivity Disorder (ADHD), which also presents with poor 
attentional and emotional regulation [18].   
 
In response to the urgent need for the early identification of individuals at high risk 
for BD there have been several attempts to develop and validate screening instruments. 
In adults, one of the most widely studied screening instruments is the Mood Disorder 
Questionnaire (MDQ) [19], a self-report questionnaire based on the Diagnostic and 
Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria for mania [10]. A 
positive MDQ screen is based on participants endorsing 7 or more lifetime manic 
symptoms, several co-occurring, resulting to moderate or serious functional 
impairment. In outpatient psychiatric settings the MDQ was reported to achieve 
sensitivity and specificity rates of 67%-83% and 86%, respectively [5]. Although 
specificity and sensitivity are theoretically independent of prevalence in practice as they 




mild cases) and interviewers’ assumptions about the frequency of a disorder [20]; 
typically, in general population samples sensitivity is lower and specificity is higher than 
that reported in clinical populations. For example, the sensitivity and specificity of the 
MDQ in the general population are respectively 23-25% and 97-99% [21, 22]. 
Additionally, many individuals with MDD, anxiety disorders or ADHD screen positive on 
the MDQ [22, 23].  
 
A significant number of screening instruments for juvenile BD have been developed 
and have been used mostly in clinical populations. These include the Parent version of 
the Young Mania Rating Scale (P-YMRS) [24], the Parent General Behavior Inventory (P-
GBI) [25], the Adolescent General Behavior Inventory (A-GBI) [25], the Youth Self Report 
(YSR) [27], the Teacher Report Form (TRF) [28], the Child Mania Rating Scale (CMRS) 
[29], the Child Behaviour Checklist (CBCL) [30], and the Mood Disorder Questionnaire 
Adolescent Version (MDQ-A) [31]. The CBCL [30] is the instrument most commonly used 
to generate profiles relevant to BD in youth. The CBCL is a parent report checklist of 118 
items mapping onto multiple aspects of psychopathology over a 6-month period [30, 
32]. The CBCL items are grouped in eight behavioural domains: aggressive behaviour, 
anxiety/depression, attention problems, rule-breaking behavior, 
withdrawal/depression, somatic complaints, social problems and thought problems 
[30]. Different scales have been generated based on varied combinations of these 
behavioural domains. Of relevance to BD, are the Externalizing Scale (comprising items 
scores from the rule-breaking and aggressive behaviour domains) and the  CBCL-
Pediatric Bipolar Disorder scale (CBCL-PBD) (comprising scores from the aggressive 
behavior, anxiety/ depression and attention problems domains) [33]. The CBCL-PBD is 
also referred to as the Dysregulation Profile as it has been associated with disorder 
involving extensive behavioural and emotional dysregulation [34] including BD [35]. 
However all available instruments have limited specificity for BD as they have been 




Therefore there is still a need for screening instruments for BD particularly for use in 
non-clinical populations of young individuals. In an attempt to address this need we 
developed and evaluated a new screening scale for BD in children and adolescents 
based on the CBCL 6-18 [30]. Despite the limited success of previous CBCL-based 
screening instruments for juvenile BD we decided to use it as the base of the new scale 
because of its cross-cultural generalizability [41]. However, instead of using summary 
scores of the existing behavioural domains we constructed this new scale following the 
methodology defined for DSM-oriented subscale development by Achenbach et al. 
(2003) [42]. Content validity of the new scale was evaluated by an expert panel of child 
and adolescent psychiatrists who selected 19 CBCL items that relate directly to the 
diagnostic criteria for mania as currently operationalized in the DSM-IV (details of the 
process are available in the supplemental material). The new scale called CBCL-Mania 
Scale (CBCL-MS) was tested for its psychometric properties, sensitivity and specificity on 
data from the TRacking Adolescents’ Individual Lives Survey (TRAILS) 
[http://www.trails.nl/en/] [43]. TRAILS is a prospective study of an epidemiologically 
representative cohort of 2230 Dutch adolescents who were assessed with the full CBCL 
at age 11, 13 and 16. Clinical outcomes were evaluated at age 19 using the Composite 
International Diagnostic Interview (CIDI) [44]. We also compared the performance of the 
CBCL-MS against the CBCL-Externalising Scale and the CBCL-PBD to test whether it 






The sample consisted of participants of the TRacking Adolescents’ Individual 
Lives Survey (TRAILS).  The sampling procedure and cohort details for TRAILS have been 
previously described in detail [43] and can be found at the study website 
[http://www.trails.nl/en/]. Briefly, the cohort includes children born between 1 October 
1989 and 30 September 1991 in a well-defined geographic area in the north 
Netherlands (information about the representativeness of the sample is included as 
supplemental material). Permission to use anonymised data from the TRAILS was 
granted by the study management committee and ethical approval was granted by the 
Dutch Central Committee on Research Involving Human Subjects (CCMO). All data were 




At ages 11, 13 and 16 years the parents or parent surrogates of TRAILS cohort 
members completed the CBCL 6-18. Each CBCL item was scored on a three point scale 
(0=not true, 1=somewhat or sometimes true, 2=very true or often true) on the basis of 
the preceding 6 months. At age 19 the diagnostic status of the TRAILS participants was 
ascertained using the Computer Assisted Personal Interview version 20 (CAPI) of the 
CIDI [http://www.hcp.med.harvard.edu/wmhcidi/].  The CIDI is a comprehensive, 
structured interview which was used by trained lay interviewers to assess mental 
disorders according to the definitions and criteria of the ICD-10 and the DSM-IV. 
It has high test-retest reliability for the diagnosis of BD type I (BD-I) [45] as well as 
excellent concordance rates with the Structured Clinical Interview for DSM-IV (SCID) for 
lifetime bipolar spectrum disorders [46]. Diagnostic assessments were conducted blind 
to participants’ CBCL scores.   
 




An expert panel of child and adult psychiatrists, based at the Institute of 
Psychiatry and the South London and Maudsley NHS Foundation Trust, independently 
screened all CBCL items to select those that correspond to the DSM-IV operational 
criteria for mania. As the diagnostic criteria for mania in DSM-IV and ICD-10 are identical 
[www.who.int/classificatios/icd/en/GRNBOOK.pdf] this selection is applicable to both 
diagnostic systems. In addition, the panel considered CBCL items relating to psychotic-
like experiences as childhood and adolescent psychotic-like experiences and high CBCL 
total scores are frequently associated with later development of mania [37-40]. 
Following consensus meetings, 19 items were selected for inclusion in the new CBCL- 
Mania Scale (CBCL-MS) (Table 1). Detailed information on the item selection procedure 
is included as supplemental material to this article. The scoring of the CBCL-MS at each 
assessment age was based on summing the scores of each of the 19 individual items. 
Scores were then standardized (T scores) following the scoring procedure recommended 
by Achenbach and Rescorla (2001) [32] using the TRAILS data as the standardization 
sample. Standardization of the CBCL scores for the CBCL-MS, as well as for other CBCL-
based syndrome scales, was performed separately for each wave. The CBCL-MS and its 
scoring are available in Appendix 1. 
 
Statistical Analysis 
Analyses were performed using IBM SPSS Statistics, Version 19 (www.spss.com) 
and MPlus 6.0 (www.statmodel.com).  
 
Reliability and validity of the CBCL-MS 
  As the CBCL-MS is a new scale the consistency of its items at each assessment 
wave was evaluated using Cronbach’s alpha. Cronbach’s alpha is an index of the 
reliability of a scale and is calculated by means of the average correlation of the items of 
the scale. It takes values from 0 to 1 with higher scores indicating higher reliability [47]. 
In order to determine the number of factors that best describe the latent factor 




the shape of the scree plot, parallel analysis using a permutated data approach (number 
of data sets: 5000; confidence interval 95%) [48, 49], the Kaiser criterion as an upper 
bound for the number of factors to be retained, and the interpretability of the obtained 
factor structure. In order to conduct the parallel analysis, principal components analysis 
(PCA) was performed first, with oblique or varimax rotation (as appropriate). PCA is a 
dimensionality reduction technique which reduces the number of items (observed 
variables) to a number of principal components which account for most of the variance 
of the observed variables. We selected PCA instead of an Exploratory Factor Analysis 
(EFA) as it represents a less conservative data reduction technique [50]. The main 
difference between the two is that EFA assumes error variance by estimating the 
commonalities, while in a PCA framework they are assumed to be initially 1. Yet, the 
relationship between the observed variables and the underlying constructs was then 
confirmed using a Confirmatory Factor Analysis (CFA) which is traditionally used to test 
the relationship pattern statistically. For each assessment age, the model fit of the final 
solutions was assessed using two fit indices, the Root Mean Square Error of 
Approximation (RMSEA) (cut-off values less than 0.06 indicate good fit and values as 
high as 0.08 represent reasonable errors of approximation in the population) and the 
Confirmatory Fit index (CFI) (cut-off values above 0.90-0.95 indicate good fit) [51]. 
 
 
Sensitivity and Specificity of the CBCL-MS 
  Omnibus tests using the standardized T scores of the CBCL-MS, the CBCL-
Externalizing Scale and the CBCL-PBD and were performed to compare the scores of 
participants with CIDI diagnoses of BD type I (BD-I) to those of healthy participants and 
participants with other CIDI diagnoses that are considered relevant to BD as they involve 
mood abnormalities (anxiety or depression), or inattention and behavioral disruption.  
We present data on Major Depressive Disorder (MDD), General Anxiety Disorder (GAD), 
and ADHD as the most pertinent exemplars. Finally, Receiver Operating Characteristics 




PBD and CBCL-Externalizing Scale. A ROC curve illustrates the sensitivity (true positive 
rate) of different cut-offs on the y axis and the 1-specificity (false positive rate) of the 
corresponding cut-offs on the x axis. In the ROC analysis, the area under the curve (AUC) 
statistic provides a summary of test performance. AUC values range from 0 to 1 with 
higher values denoting greater discriminative power and diagnostic efficiency.  The 
focus of the analysis was on BD-I as the usefulness of a test with poor discriminative 
ability for core syndromal BD would be questionable. However, we also performed ROC 
analysis using a more expanded definition of caseness that also included BD type II (BD-

























TRAILS participants with BD 
At age 19, 56 of the TRAILS participants were diagnosed with BD-I. Sixteen of the 
BD-I cases had a previous diagnosis of BD-II while 34 had attracted other psychiatric 
diagnoses prior to being diagnosed with BD; seventeen had a single previous diagnosis 
either for Oppositional Defiant Disorder (ODD) (n=5) or Conduct Disorder (CD) (n=5) or 
ADHD (n=4) or GAD (n=3). Of the remaining seventeen BD cases, eleven had two prior 
diagnoses (ADHD/ODD=2, ADHD/CD=1, ADHD/GAD=1, ADHD/MDD=1, ODD/CD=3, 
ODD/GAD=2, ODD/MDD=1), five had three prior diagnoses (ODD/CD/GAD=3, 
ODD/CD/ADHD=2) and one had four (ODD/CD/ADHD/GAD). 
      
Internal consistency and factor structure of the CBCL-MS  
Reliability analysis demonstrated high internal consistency for the 19 items of 
the CBCL-MS at all assessment ages (Cronbach’s alpha≥80; total item correlation >0.37). 
A PCA of the CBCL-MS data assessed at age 16 extracted four factors corresponding to: 
(1) distractibility/ disinhibition (2) psychotic symptoms (3) increased libido (4) disrupted 
sleep (Figure 1). These factors were plausible and interpretable as items’ loading 
segregated among the four factors as shown in Table S1, available on line. The factor 
structure represents the orthogonal solution of the PCA, as the factors extracted using 
oblique rotation were only weakly correlated (r<.3). The Parallel analysis and Kaiser’s 
criterion both supported the retention of four factors. The scree plot of the extracted 
eigenvalues from the parallel analysis is given in supplemental Figure S1, available on 
line. Analyses of the CBCL-MS data at ages 11 and 13 years resulted in an almost 
identical factor structure indicating longitudinal stability of this solution (Tables S1, S2 
and S3, supplemental material available on line). Confirmatory factor analyses further 
supported the goodness of fit of 4-factor structure (RMSEA≤0.05 and CFI≥0.92).  
  




Table 2 presents the mean total and CBCL-MS factor scores for TRAILS 
participants who were diagnosed with BD-I and for those who did not have any lifetime 
psychiatric diagnosis. Participants with BD had significantly higher mean total CBCL-MS 
scores compared with participants with MDD (n=178; p=0.002) and GAD (N=20; 
p=0.004) but not ADHD (N=26; p>0.05) (Figure 3).  
 
The ROC curve analysis on the CBCL-MS data at age 16 is illustrated in Figure 2. 
The AUC was 0.64 (p<0.01) which represents a satisfactory performance for a general 
population sample with low prior probability of true positives. The AUC remained 
unchanged when caseness was expanded to include BD-II and hypomania without major 
depressive episode. Moreover, the total CBCL-MS score performed better than the 
scores of each individual factors used independently or sequentially (details in 
supplemental material, Table S4 and S5). 
 
 We identified two cut-off scores that respectively optimise sensitivity or 
specificity that could be selected depending on the intended use. For a CBCL-MS cut-off 
score of 43 (i.e. one standard deviation below the population mean) sensitivity and 
specificity were 82% and 30% respectively.  For a CBCL-MS cut-off score of 60 (i.e. one 
standard deviation above the population mean) sensitivity and specificity were 33% and 
90% respectively.  A CBCL-MS cut-off score of 70 corresponds to the clinical cut-off score 
for CBCL subscales (i.e. 2 standard deviations above the populations mean) proposed by 
Achenbach et al. (2001) [32] and yields sensitivity and specificity values of 23% and 97% 
respectively. 
 
Comparison to CBCL-PBD:   TRAILS participants with BD-I had significantly higher 
CBCL-PBD mean scores (56.51, SD=15.91) in comparison to healthy participants (49.79, 
SD=9.69) but not compared to participants with MDD (p=0.54), GAD (p=0.51) or ADHD 
(p=0.37). ROC curve analysis showed a moderate ability of the CBCL-PBD in 





 Comparison to the Externalizing scale of the CBCL: Externalizing scale mean scores 
were significantly higher for TRAILS participants with BD-I (58.49, SD=18.27) in 
comparison to healthy participants (48.44, SD=8.25) and participants with MDD (52.00, 
SD=9.80) or GAD (50.52, SD=7.80), but not compared to participants with ADHD (p=.23). 
ROC analysis showed that the Externalizing scale had AUC=63%, p=.003 when 
discriminating between TRAILS cases with BD-I and healthy participants.  
 
 A forward stepwise logistic regression model showed that the CBCL-MS had 
significantly increased ability to predict BD-I compared to the CBCL-PBD (Wald χ2= 12.69, 





 We present data on the psychometric properties and discriminative ability of the 
CBCL-MS, a new DSM based screening scale for BD-I based on the CBCL. We 
demonstrate that the new scale has excellent psychometric properties; its discriminative 
ability and accuracy in a general population sample of young people represent an 
improvement over other commonly used scales particularly CBCL-PBD and the CBCL-
Externalizing Scale. 
 
Prevalence and Characteristics of TRAILS participants with BD 
 The lifetime prevalence of BD-I in the TRAILS sample was 2.5% which is identical to 
that reported in a recent epidemiological study of US adolescents [53].  Also consistent 
with previous literature, nearly 61% of BD-I cases in the TRAILS sample had prior 
diagnoses associated with disruptive behaviour most commonly ADHD and ODD [18, 53-
56]. 
 
Reliability and validity of the CBCL-MS 
 The reliability of the CBCL-MS as assessed using Cronbach’s alpha was satisfactory 
(>80%) at all assessment points. The main disadvantage of using Cronbach’s alpha arises 
from the fact that it is based on the inter-item correlations and can therefore be 
affected by the homogeneity of subject responses on the items. Yet, it is considered to 
be the most widely used index of reliability due to its power, simplicity and ease of 
interpretation [57].   
  
Moreover, the CBCL-MS satisfied different validity criteria necessary in the 
development of new scales. Firstly, the items of the CBCL-MS were selected by an 
expert panel to map onto DSM-IV diagnostic criteria for Mania, thus ensuring face and 
content validity. In addition, construct and criterion validity of the CBCL-MS was 
established by means of PCA, ROC analysis, regression models and ANOVAs. Construct 




performance of the test and how plausible they are while criterion validity refers to how 
well a set of variables predicts an outcome [58]. The extraction of four plausible and 
interpretable factors corresponding to symptoms dimensions of BD as described in 
previous research [56, 59-62], the high discriminative ability of the CBCL-MS to 
distinguish between BD cases and healthy controls as well as a significant regression 
model between the CBCL-MS and BD-caseness provided support for the construct and 
criterion validity of the CBCL-MS. Moreover, external validity has been defined in the 
seminal work of Campbell and Stanley (1963) as an index of the generalizability of the 
findings to other samples, times, measures and settings [63]. The external validity of the 
CBCL-MS was therefore established for the CBCL-MS by the representativeness of the 
sample (Table S6) and the extraction of the same principal component structure across 
assessment points. The association between the scores of the CBCL-MS and other 
instruments measuring manic symptomatology was not assessed in this study as the 
CBCL was the only available instrument; therefore, the convergent and divergent 
validity of the CBCL-MS is yet to be established in future studies.      
 
Factor Structure of the CBCL-MS reveals developmentally meaningful dimensions of 
liability to BD 
The structural model of the CBCL-MS consisted of four factors. These factors 
correspond to dimensions of distractibility/disinhibition, psychosis, increased libido and 
disrupted sleep. The factor structure of the CBCL-MS showed remarkable temporal 
stability between the ages of 11 to 16 which strongly supports the notion that it defines 
developmentally meaningful dimensions of liability to BD. This report is the first to 
describe developmental dimensions of liability to BD. All other studies have focused on 
symptom dimensions during acute manic episodes in patients with established BD [56-
59-62]. Nevertheless, there are significant similarities. Cassidy and colleagues identified 
5 factors in acute mania of which the “psychomotor pressure”, “psychosis” and 
“increased hedonic” factors correspond to the distractibility/disinhibition, psychosis and 




structure of acute mania based on the Brief Psychiatric Rating Scale. The factors they 
named “mania” and “disorganisation” include items similar to the 
distractibility/disinhibition factor identified here. In addition their “positive symptoms” 
factor overlaps with the psychosis factor in this study. Cassano et al [61] identified 5 
factors in acute mania of which “psychomotor agitation” and “psychoticism” correspond 
to the factors of distractibility/disinhibition and psychosis in the TRAILS cohort. All three 
studies also defined factors relating to dysphoric/euphoric mood and aggression that 
seem to be present only during acute mania and may not represent an independent 
dimension of developmental liability to BD. 
  
In this study we treated each measurement wave separately under the assumption of 
measurement invariance. Measurement invariance represents the extent to which the 
psychometric properties of the observed variables can be generalised across groups or 
over time. Commonly, measurement invariance is assumed to hold in any statistical 
analysis but it can also be tested explicitly under latent modelling frameworks, e.g. EFA.   
Milfont et al. (2010) have described different types of invariance for multigroup analyses 
which can also be expanded to assess longitudinal invariance [64]. There are two main 
types of longitudinal invariance; a) measurement invariance including invariance of 
factor loadings, item intercepts and residual variances across assessments; and b) 
structural invariance including invariance of the factor variances, covariances and means 
over time. The first type of measurement invariance examines whether the construct is 
measured in the same way at each assessment point while structural invariance 
assesses differences in the distribution and the means of the constructs over time. 
These types of analyses exceeded the scope of this study as the PCAs and parallel 
analyses provided support for the structure of the components of the CBCL-MS 
extracted across assessment points and they were comparable to the aforementioned 
research [56, 59-62]. Nonetheless, future studies on the longitudinal stability of BD 





Discriminative ability of the CBCL-MS 
The overall accuracy was 0.64 for the CBCL-MS and CBCL-Externalising Scale and 
0.61 for the CBCL-PBD. The results of the logistic regression comparing the three scales 
showed that the CBCL-MS was statistically better in predicting BD outcome.   
As seen by the ROC, different cut-off scores will influence the sensitivity and 
specificity of the CBCL-MS. A cut-off score of 43 increases sensitivity while maintaining 
acceptable specificity while increasing the cut-off score to 70 increases specificity while 
maintaining acceptable sensitivity. In general population screening the emphasis is 
usually on specificity thus selecting individuals at highest risk for detailed follow-up 
assessments. To illustrate this point, in a hypothetical community sample of 10000 
youth with a 2.5% prevalence of BD we would expect 250 individuals to have BD (true 
positives). A CBCL-MS score of 70 or above will correctly identify 8,775 individuals (90% 
of this sample) as not having BD (true negatives). At the same threshold, 1,050 
individuals will be classified as possible cases. This sample will include 75 true cases of 
BD (true positives) and 975 individuals without BD (false positives).  At first glance, one 
might be concerned about the number of false positive cases. However, those scoring 
above 70 in the CBCL-MS were at a six-fold increased risk for BD (Positive Predictive 
Value: 16.57%; Negative Predictive Value: 98.01%) compared to the rest of the sample 
and therefore they represent a high risk group. The field of early intervention in BD is 
currently in its infancy [65] but as effective therapies become available [66] scales such 
as the CBCL-MS may contribute to the identification of those at high risk. 
 
None of the scales differentiated participants with BD from those with ADHD in 
terms of mean scores. The relationship between these two disorders is complex. 
Available evidence suggests at least partially overlapping aetiology and pathophysiology 
for BD and ADHD because of familial co-segregation of the two disorders [67, 68], 
commonalities in their neurobiological correlates [18, 69, 70], and frequent comorbidity 
[18]. Additionally, there is significant overlap in the symptoms of the two disorders 




[10, 11]. Two main features distinguishing BD from ADHD have been proposed. Geller 
and colleagues emphasized the importance of either elevated mood or grandiosity for a 
diagnosis of mania [71]. However, in our study these symptoms clustered with others in 
one factor and did not differ across the two diagnostic categories. Others have 
suggested that episodicity is more indicative of BD than ADHD [72] but this distinction 
seems less clear in children and adolescents [53]. It is therefore possible that scales 
based on observed behaviour lack assay sensitivity in distinguishing between BD and 
ADHD.  
 
Methodological Issues and Future Directions 
    The present study has a number of strengths and limitations. The TRAILS sample is 
representative of the population of young people in the Netherlands (supplemental 
Table S6). The prevalence of BD in the TRAILS is nearly identical to that of general 
population samples elsewhere [1,53] which supports the generalizability of findings. 
Case ascertainment in the TRAILS does not depend on help-seeking behaviour or 
concern about impairment or severity and thus the sample is free from referral bias 
present in clinical populations. However, the CIDI although widely used is designed for 
lay interviewers who rely on its structured format and may not probe or interpret 
participant responses further. Case ascertainment was conducted at age 19. Since 
participants have not yet passed the entire period of risk for BD it is possible that further 
cases of BD may present in the future.   
 
The CBCL-MS performed well within the context of a general population sample, 
it represents an improvement on available scales and could contribute to future public 
health initiatives for the identification of youth at high risk for BD. Its accuracy is 
moderate and in the same broad range of the other CBCL-based screening instruments. 
Although it could be argued that this is reflects limitations in the CBCL we would suggest 
that behavioural ratings alone are unlikely to provide us with high levels of accuracy in 




However a great strength of this study was the availability of CBCL assessments 
at multiple time points from late childhood to early adulthood. This allowed us to test 
the temporal stability of the CBCL-MS factors which supports the validity of these 
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Figure 1. Factors and Factor Loadings of the Child Behavior Checklist-Mania Scale 
 
Figure 2. Receiver Operating Characteristics curve of the Child Behavior Checklist-Mania 
Scale for Bipolar Disorder vs. healthy TRAILS participants 
 





Table 1. Child Behavior Checklist-Mania Scale items and corresponding core and 
extended DSM-IV criteria for Mania  
CBCL Items DSM-IV criteria for Mania 
Core Symptoms 
37. Gets in many fights 
87. Sudden changes in mood or 
feelings  
96. Thinks about sex too much 
A distinct period of abnormally and 
persistently elevated, expansive or 
irritable mood 
74. Showing off or clowning 
94. Teases a lot 
Inflated self-esteem or grandiosity 
76. Sleeps less than most kids  
100. Trouble sleeping 
Decreased need for sleep (e.g., feels 
rested after only 3 hours of sleep) 
93. Talks too much 
104. Unusually loud 
More talkative than usual or pressure to 
keep talking  
Flight of ideas or subjective experience 
that thoughts are racing 
78. Inattentive or easily 
distracted 
Distractibility (i.e., attention too easily 
drawn to unimportant or irrelevant 
external stimuli) 
10. Can’t sit still, restless or 
hyperactive 
60. Plays with own sex parts too 
much 
Increase in goal-directed activity (at work, 
at school, or sexually) or psychomotor 
agitation 
41. Impulsive or acts without 
thinking  
59. Plays with own sex parts in 
public 
 
Excessive involvement in pleasurable 
activities that have a high potential for 
painful consequences (e.g., engaging in 
unrestrained buying sprees, sexual 
indiscretions, or foolish business 
investments) 
Extended Symptoms 
34. Feels others are out to get 
him/her  
85. Strange ideas  
89.Suspicious 
Delusions 
40. Hears sound or voices that 
aren’t there 






Table 2. Child Behavior Checklist-Mania Scale total and Factor Scores in TRAILS 









 Mean Score (Standard Deviation) p 
Total CBCL-MS 57.28 (16.08) 49.33 (8.95) <0.001 
Distractibility/Disinhibition 56.01 (14.71) 49.18 (8.98) <0.001 
Psychotic Symptoms 56.19 (20.20) 49.44 (8.84) <0.001 
Increased Libido 51.99 (12.28) 49.48 (8.88) 0.088 































Figure 2. Receiver Operating Characteristics curve of the Child Behavior Checklist-

































Selection of Items 
We followed a typical content validity procedure (Grant & Davis, 1997; Lengua et al, 
2001) which involves content experts who judge each item of an instrument against the 
definition of the domains intended to measure and score its relevance on a 4-point scale 
ranging from 1 (irrelevant) to 4 (highly relevant). In our study, content validity was 
assessed by a panel of 10 qualified child and adolescent psychiatrists (average number 
of years of clinical and research experience: 8; range: 4—20 years). These experts were 
representative of the professional settings (inpatient, outpatient, academic) within the 
South London and Maudsley NHS Foundation Trust. They rated the relevance of each 
item from the total item pool of the CBCL 6-18 on a scale of 1-4 against each of the 
symptom domains of mania as defined in the DSM-IV. The content validity index (CVI) 
for each item was established by calculating the proportion of experts scored it as 
relevant (score 3) or highly relevant (score 4) for any of the domains. A minimum item 
CVI of 0.80 (Grant & Davis, 1997) was required for inclusion in the second stage where 
final item inclusion to the CBCL-MS was based on unanimous agreement.  
 
Psychometric properties of CBCL-MS across ages 
Reliability analyses demonstrated high internal consistency for the 19 items of the CBCL-
MS at all assessment ages (Cronbach’s alpha≥0.80; item total correlation >0.37). PCA 
analyses of the CBCL-MS data at ages 11, 13 and 16 years resulted in an almost identical 
factor structure and explained 48.18%, 46.06% and 44.94% of the variance of the items 
respectively. The four factors corresponded to: (1) distractibility/ disinhibition (2) 
psychotic symptoms (3) increased libido (4) disrupted sleep. Items’ loading for the four 
factors are shown in Table S1-S3. Parallel analyses and Kaiser’s criterion both supported 
the retention of four factors. The scree plot of the extracted eigenvalues from the 
parallel analysis at age 16 is given in Supplemental Figure S1. Fit indices of Confirmatory 




Approximation (RMSEA) values were 0.04, 0.04 and 0.05, and Confirmatory Fit index 
















Table S1. Items, factors and item loadings of the CBCL-MS at age 16 








41. Impulsive or acts 
without thinking 
.711 .109 .043 .025 
10. Can’t sit still, restless 
or hyperactive 
.680 .053 .081 .108 
78. Inattentive or easily 
distracted  
.676 .002 .117 .047 
104. Unusually loud .672 .177 .038 .073 
74. Showing off or 
clowning 
.637 .092 .018 .070 
93. Talks too much .623 .007 .103 -.047 
94. Teases a lot .423 .390 -.145 .159 
87. Sudden changes in 
mood or feelings 
.411 .299 .237 -.093 
96. Thinks about sex too 
much 
.407 -.026 .201 .001 
85. Strange ideas  .028 .662 .301 -.101 
37. Gets in many fights  .290 .534 -.131 .225 
70. Sees things that 
aren’t there  
-.027 .464 .326 -.054 
40. Hears sound or 
voices that aren’t there 
-.074 .457 -.054 .137 
89.Suspicious .406 .448 .150 -.169 
34. Feels others are out 
to get him/her 
.384 .436 .055 -.108 
100. Trouble sleeping .162 .127 .796 .030 
76. Sleep/s less than 
most kids 
.209 .038 .769 .097 
59. Plays with own sex 
parts in public 
.029 .109 .055 .793 
60. Plays with own sex 
parts too much 






Table S2. Items, factors and item loadings of the CBCL-MS at age 13 








41. Impulsive or acts 
without thinking 
.704 .055 .014 .061 
104. Unusually loud .696 -.022 .024 .108 
10. Can’t sit still, restless 
or hyperactive 
.695 -.041 .060 .052 
78. Inattentive or easily 
distracted 
.680 .068 .050 .080 
74. Showing off or 
clowning 
.671 .126 -.021 -.029 
93. Talks too much .597 -.033 -.035 .158 
94. Teases a lot .561 .213 .120 -.053 
87. Sudden changes in 
mood or feelings 
.489 .169 -.013 .226 
89.Suspicious .406 .394 -.087 .152 
37. Gets in many fights .399 .273 .119 -.122 
96. Thinks about sex too 
much 
.313 .176 .272 -.048 
70. Sees things that 
aren’t there 
-.003 .789 -.063 .025 
40. Hears sound or 
voices that aren’t there 
-.036 .664 .140 .056 
34. Feels others are out 
to get him/her 
.116 .497 .050 .095 
85. Strange ideas .347 .371 -.023 .107 
60. Plays with own sex 
parts too much 
-.017 .076 .842 .045 
59. Plays with own sex 
parts in public 
.054 -.029 .825 .015 
76. Sleeps less than 
most kids 
.097 .117 .014 .827 







Table S3. Items, factors and item loadings of the CBCL-MS at age 11 








104. Unusually loud .750 .128 .049 .055 
74. Showing off or 
clowning 
.706 .140 .046 .048 
10. Can’t sit still, restless 
or hyperactive  
.681 .017 .077 .055 
78. Inattentive or easily 
distracted 
.678 .076 .064 .049 
41. Impulsive or acts 
without thinking  
.676 .138 .034 .098 
94. Teases a lot .628 .078 .041 .031 
93. Talks too much .585 .047 .072 .075 
87. Sudden changes in 
mood or feelings 
.532 .306 .094 -.086 
37. Gets in many fights .524 .037 .001 .179 
70. Sees things that 
aren’t there 
.027 .706 .073 .053 
40. Hears sound or 
voices that aren’t there 
-.071 .685 .018 .182 
85. Strange ideas .185 .539 .070 .086 
89.Suspicious .329 .483 .100 -.039 
34. Feels others are out 
to get him/her 
.392 .470 .031 -.108 
76. Sleeps less than 
most kids 
.138 .067 .857 .030 
100. Trouble sleeping .065 .166 .843 .009 
60. Plays with own sex 
parts too much 
.082 .041 -.034 .825 
59. Plays with own sex 
parts in public 
.003 .214 -.050 .703 
96. Thinks about sex too 
much 







Discriminative ability of the CBCL-MS 
We examined the discriminative ability of each factor and of the total CBCL-MS score at 
the cut-off point of 1 standard deviation above their corresponding population mean. 
The results are shown in Table S4. 
 
Table S4. Discriminative ability of the total CBCL-MS and its factors 
 Area Under the 
curve (p value) 
Sensitivity Specificity 
CBCL-MS 0.64 (0.003) 0.33 0.90 
Distractibility/Disinhibition 0.63 (0.004) 0.25 0.87 
Psychosis 0.57 (0.097) 0.17 0.94 
Increased Libido 0.53 (0.403) 0.17 0.98 
Disrupted Sleep 0.56 (0.167) 0.23 0.90 
 
 
The total CBCL-MS score had better discriminative ability than each of the individual 
factor scores. We then tested whether sequential application of the factors improved 
predictive ability for BD over that achieved using the composite CBCL-MS alone. We 
conducted two regression analyses, a stepwise forward logistic regression model using 
the 4 factors as predictors and a regression model using the total CBCL-MS score as the 
single predictor. The final model of the stepwise forward logistic regression contained 
only the distractibility/disinhibition factor suggesting that none of the remaining three 
factors improved predictive accuracy (all p values of the competing regression 
models>.05). However, the Nagelkerke R2 for this model was 1.2% less than that 
obtained from a regression model using the total CBCL-MS score as a single predictor 














Table S5. Regression Models  






Psychotic Symptoms -- -- -- .07 





Increased Libido -- -- -- .74 
15.19, 
p<.001 








Stepwise Forward Regression Model  
 
Therefore, the CBCL-MS appears to be better in terms of its predictive accuracy for BD 
as a single composite scale in comparison to its factors either used individually or in 
tandem. 
 
Representativeness of the TRAILS sample 
The TRAILS cohort was identified through birth and school registers in the 5 northern 
municipalities of Holland. Recruitment was based on entire schools participating; 91% of 
all the schools in the municipalities agreed to take part. Table S6 shows that key 
variables regarding representativeness of the TRAILS cohort are comparable to those 
from the 2001 Dutch national census. 
 
Table S6. Characteristics of TRAILS participants at enrolment compared to the 2001 
national census data available online from the Centraal Bureau voor de Statistiek 
(www.cbs.nl) 
 TRAILS  2001 Dutch Census  
% Girls 50.8% 48.8%1 
% White European 89.4% 93.2%1 
Lower parental education2 32.6% 30.6% 
% children living with both parents3 84.5% 84% 
Median disposable household income  21780 Euros 20700 Euros 
1 
The census reported on the 10-15 years age range; 
2
Defined as having completed up to lower half of  
secondary school 
2






Data Availability  
The collection, management and distribution of the TRAILS data are coordinated by the 
University Medical Center Groningen, The Netherlands. Details can be found at the 
study website: www.trails.nl. The study management committee is open to requests by 
all researchers for the use of anonymised data from the TRAILS. Further information 
about the process can be requested via e-mail: trails@med.umcg.nl. 
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Objective: Screening and clinical guidance development for medical disorders are based 
on “alarm symptoms”, clinical features known to predict disease. Our aim was to define 
and evaluate the concept of “alarm symptoms” for broadly defined Bipolar Disorder 
(BD) in a population based study.  
Methods: We used latent class analysis to model the relationship between subclinical 
manic symptoms collected with the Child Behaviour Checklist-Mania Scale (CBCL-MS) at 
age 11 years and syndromal diagnosis of BD by age 19 years in a cohort of 2230 Dutch 
adolescents participating in the TRacking Adolescents’ Individual Lives Survey. Sex, 
socioeconomic status, cognitive ability, parental psychiatric morbidity and family 
dysfunction were also considered in the model. 
Results: LCA of CBCL-MS items identified three classes, representing an asymptomatic 
class (n=862), a mildly symptomatic class (n=845) and a highly symptomatic class 
(n=199). The odds ratio of subsequent BD was 2.66 (95% CI 1.41-5.02) in the mildly and 
7.1 (95% CI 3.31-15.11) in highly symptomatic class.  The risk for depression, anxiety and 
substance abuse disorders was not associated with class membership. Significant 
deviance in mood lability, impulsivity, inattention and increased activity and speech 
were identified as “alarm symptoms”; this symptom cluster had a positive and negative 
predictive value for BD of 13.2% and 96.3% respectively.  
Conclusions: Our results support the concept of “alarm symptoms” in BD, as highly 
deviant childhood manic symptoms were associated with a subsequently greatly 








There is currently much interest in the childhood antecedents of Bipolar Disorder (BD) 
based on three lines of evidence. The first line derives from follow-back studies of adult 
patients with BD; the majority report subthreshold symptoms in childhood and 
adolescence and date the onset of their illness between the ages of 13-18 years (1-3). 
The second line is based on prospective evaluations of individuals at high risk for BD by 
virtue of having at least one affected parent (4). Offspring of BD parents often present 
with mood lability, depression, elevation or irritability, changes in energy levels and 
decreased sleep (5-7). Cognitive problems and family dysfunction further increase the 
risk of subsequent BD (8, 9). The third line of evidence comes from studies that 
examined the prevalence and predictive value of subclinical manic symptoms in general 
population samples of youth using repeated assessments over follow-up periods of 10-
16 years (10-14). Subclinical manic symptoms were found to be relatively common (5-
25%) (11, 12) and were mostly transient (13, 14). Their predictive value for BD was 
limited except when symptoms persisted throughout adolescence (13). However, the 
future course of subclinical manic symptoms is unknowable and thus of limited value in 
the clinical evaluation of individuals presenting in childhood. In addition, subclinical 
childhood manic symptoms showed modest associations with childhood diagnoses of 
disruptive behavior disorders and adult diagnoses of anxiety, depression and substance 
abuse (11).  
Subclinical manic symptoms in childhood are therefore imperfect predictors of 
clinical outcome. The problem of imperfect prognostic indicators is not unique to 
psychiatry but applies to multiple fields of medicine. The early detection of cancer is a 
key example.  Most of the early symptoms of cancer are non-specific (e.g. weight loss, 
fatigue, persistent coughing) and highly prevalent in the general population (15). 
Nevertheless, clinical features considered predictive of malignancy, often termed “alarm 
symptoms”, form the basis of public awareness campaigns and of clinical guidelines 
(www.cancer.org). Conventionally, “alarm symptoms” with a positive predictive value 




≥5% are used to identify those in need of further evaluation (16). There is no similar 
provision for BD despite increased mortality rates and reduced life expectancy by 12-14 
years (17). Extending the concept of “alarm symptoms” to BD may provide a useful 
framework for the evaluation of subclinical manic states in youth in order to identify 
underlying BD at an earlier and more amenable stage.  
  
 To address this issue, we examined data from the TRacking Adolescents’ Individual Lives 
Survey (TRAILS) (www.trails.nl) which followed a representative general population 
cohort of 2230 Dutch children from age 11 to age 19 years (18, 19).  Our objectives were 
to (a) specify the number of underlying categories (latent classes) of TRAILS participants 
according to their subclinical manic symptoms profile, (b) ascertain the predictive value 
of class membership for subsequent syndromal BD, (c) to define “alarm symptoms” for 
BD based on the predictive value of the subclinical manic symptom profile of each class 
and, (d) to determine the contribution to class membership of key risk factors 








The TRacking Adolescents’ Individual Lives Survey (TRAILS) (www.trails.nl) is a 
prospective longitudinal study of a representative population cohort of 2230 individuals 
born in northern Netherlands between 1 October 1989 and 30 September 1991.  Details 
of the TRAILS design, sampling and assessments have been described elsewhere (18) 
and are summarised in supplemental material and supplemental Table S1. Ethical 
approval was granted by the Dutch Central Committee on Research Involving Human 
Subjects (CCMO) and permission to use anonymised data from the TRAILS was granted by 
the study management committee.  
Cohort members were assessed at baseline when aged 11 years (n=2230) and 
then at age 13 (n=2149), 16 (n=1816) and 19 years (n=1881). The retention rate over the 
8-year follow-up period was 84.3% which is high for longitudinal studies of psychiatric 
outcomes (18, 19). TRAILS members lost due to attrition by age 19 were predominantly 
male from a lower socioeconomic background (p<0.001) but did not differ in terms of 
family functioning (p=0.15) or parental psychiatric history (p=0.22) from the rest of the 
cohort (19).  
 
Instruments  
Child Behaviour Checklist-Mania Scale (CBCL-MS) (20): Manic symptoms in the 
TRAILS cohort were captured using the CBCL-Mania Scale (CBCL-MS) which comprises 19 
items selected from the CBCL (6-18) (21) to correspond to core and extended symptom 
domains for mania (Table 1 and Supplemental Table S2). The development and 
psychometric properties of the CBCL-MS are described elsewhere (20) and summarized 
in the supplemental material. We have previously shown that the CBCL-MS is a valid and 
reliable tool for assessing subclinical manic symptoms with improved discriminative 
ability for BD compared to other popular scales (20).  In this analysis we used the 




Computer Assisted Personal Interview version 20 (CAPI) of the Composite 
International Diagnostic Interview (CIDI):  The CIDI is a comprehensive structured 
interview designed to be used by trained lay interviewers to yield diagnoses according 
to current classification systems (www.hcp.med.harvard.edu/wmhcidi). Lifetime 
disorders assessed in the CIDI included mood episodes and disorders (major depressive 
disorder [MDD], dysthymic disorder, mania, and hypomania), anxiety disorders 
(agoraphobia, generalized anxiety disorder [GAD], panic disorder, separation anxiety 
disorder, social phobia, and specific phobia), disruptive behavior disorders (oppositional 
defiant disorder [ODD] and conduct disorder [CD] ), attention-deficit/hyperactivity 
disorder [ADHD], substance use disorders [SA] (alcohol abuse/dependence and drug 
abuse/dependence). CIDI assessments were conducted blind to participants’ CBCL 
scores. 
In this study, we considered lifetime diagnoses based on CIDI assessment of 
participants by age 19 years. We used a broad definition of Bipolar Disorder to include 
BDI, BDII, mania and hypomania. Unless otherwise specified we will use the term Bipolar 
Disorder (BD) when we refer to all four jointly. The CIDI has high test-retest reliability for 
the diagnosis of BDI (22) as well as excellent concordance rates with the Structured 
Clinical Interview for DSM-IV (SCID) for lifetime BDII and hypomania (23). Additional 
diagnoses considered were MDD, GAD and SA.  This was based on previous evidence 
that subclinical manic states may also increase the risk for these disorders (11).  
Wechsler Intelligence Scale for Children-Revised (WISC-R) (24): An estimate of 
intellectual ability was obtained at age 11 based on a composite measure derived from 
age-normalized standard scores of the Vocabulary and the Block Design subtests of the 
WISC-R.  
General Functioning Subscale of the McMaster Family Assessment Device 
(FAD-GFS) (25):  The FAD-GFS is a 12-item scale assessing six dimensions of family 
functioning; communications, problem solving, affective responsiveness, affective 




dysfunction. In this analysis we used FAD-GFS data completed by the parents when 
participants were 11 years old. 
Parental psychiatric morbidity:  Participants’ parents were first given a 
structured checklist of symptoms and disorders with detailed explanations and were 
asked to endorse those that applied. Subsequently trained interviewers asked follow-up 
questions to clarify the diagnostic significance of the reported symptoms and elicit 
details of treatment when applicable. In total, 45.5% of children had at least one parent 
with a psychiatric disorder (details in supplemental material). Although parental BD is a 
robust indicator of concordant offspring disorder (4, 9), we did not consider individual 
parental diagnoses as risk elevation is not confined to concordant disorders (26). 
Participants with at least one parent with any psychiatric diagnosis at baseline were 
considered positive for parental psychiatric morbidity. 
 Parental Socioeconomic status: Parental Socioeconomic Status (SES) at baseline was 
measured using a composite index of five indicators:  maternal and paternal education, 
family income and maternal and paternal occupation, as defined by the International 
Standard Classification of Occupation (27). A composite index was constructed by 
averaging the five indicators upon standardization. This index was then used to specify 
three groups as low, moderate and high SES.  
   
Statistical analysis 
Latent Class Analysis was used to determine the number of underlying categories 
(latent classes) of participants needed to explain the pattern of associations between 
the 19 CBCL-MS items at age 11. IQ, parental SES, parental psychiatric morbidity and 
family function were also introduced in the model. We tested whether the data were 
explained by 1 to 4 classes with the option of testing further models if indicated. 
Multiple start values were considered for the estimated model parameters to avoid 
convergence on local, rather than global, solutions. Observing the same log likelihood 
obtained from multiple sets of start values increases confidence that the solution 




goodness of fit indices considered most robust: (a) the Bayesian Information Criterion 
(BIC); lower values indicate better fit to the data, (b) The Lo-Mendell-Rubin (LMR) 
likelihood ratio test of the hypothesis that a simpler model provides an equally good fit, 
and (c) the entropy of the model; higher entropy indicates that the latent classes are 
clearly distinguishable.  
Upon identification of the best fitting model, we examined the effect of IQ, 
parental SES, parental psychiatric morbidity and family function based on their 
regression estimates on the latent variable representing class membership. 
In order to ascertain the predictive value of class membership we used a series 
of logistic regression analyses to examine the association between class membership at 
age 11 and diagnoses of BD, MDD, GAD or SA between ages 12 to 19 years.  Amongst 
the non-BD clinical outcomes, we focused on MDD, GAD and SA based on previous 
reports that subclinical manic states may increase the risk for these disorders as well 
(11). For these analysis the threshold of statistical significance was set to p<0.01 
following adjustment for multiple comparisons.  
Finally, cox regression analysis was used to examine whether class membership 
was related to increased incidence rate for BD in addition to their potential association 
to increased cumulative likelihood of BD identified by logistic regression model.  
All analyses were performed using MPlus 6.0 (www.statmodel.com) and IBM 





In total, 86 (5.4%) TRAILS participants were diagnosed with BD by age 19. Eleven had an 
established disorder at baseline and were therefore excluded from further analyses. 
 
Classification of TRAILS participants at age 11 based on the CBCL-MS 
  The frequency of parental endorsement of each CBCL-MS item in the entire 
TRAILS sample is shown in Table 1. A 3-class solution provided the best model for 
explaining the association between CBCL-MS items as reflected in the BIC value, 
significant LMR p value (<0.0001) and higher entropy compared to the 1- and 2-class 
solutions (Table 2). The 4 and 5-class solutions had lower BIC values, but also lower 
entropy indicating worse fit (Table 2). Figure 1 presents the CBCL-MS item endorsement 
pattern in each of the 3 classes identified. 
  
Class I (n=862; 45.2% of the cohort) included children whose parents endorsed 
on average 1.36 (1.15) CBCL-MS items. Since endorsement was minimal we consider this 
an “asymptomatic class”. This is also confirmed by the low rates of disruptive disorders 
within this class, mainly ODD (2.1%), CD (1.5%) and ADHD (1.1%). Class II (n=845; 44.3% 
of the cohort) included children whose parents endorsed on average 5.76 (1.89) CBCL-
MS items. Their mean standardized CBCL-MS total score was 53.01 (4.80). A small 
proportion of children in this class (11.1%) had been diagnosed with disruptive disorders 
by age 11, mainly ODD (4. 4%), CD (4.2%), and ADHD (4.1%). We considered this a 
“mildly symptomatic class”. Class III (n=199; 10.4% of the cohort) included children 
whose parents endorsed 10.37 (2.07) CBCL-MS items. Their mean standardized CBCL-MS 
total score was 71.40 (7.34).  Additionally, 27.2% of children in this class had been 
diagnosed with disruptive disorders by age 11, particularly ADHD (14.0%), ODD (13.1%) 
and CD (7.0%). Therefore we considered this a “highly symptomatic class”.  
 




IQ, SES, family dysfunction and parental psychiatric morbidity were significantly 
associated with class membership. Children in the highly symptomatic class were 
significantly more likely to have lower IQ, lower parental SES, greater family dysfunction 
and positive parental psychiatric morbidity compared to the other two classes (Table 3 
and Figure 2). The male to female ratio was nearly equal in the mildly symptomatic class 
(1.0:0.9). However, females were overrepresented in the asymptomatic class (1.0:1.5) 
and underrepresented in highly symptomatic class (1.0:0.5).  
 
Class membership at age 11 and risk for subsequent BD 
Of the 69 TRAILS participants diagnosed with BD between 12 and 19 years, 14 
(1.6%) derived from the asymptomatic class, 33 (3.9%) from the mildly symptomatic 
class and 15 (7.5%) from the highly symptomatic class (supplemental Table S3). Class 
membership at age 11 was significantly associated with subsequent diagnosis of BD 
(χ2=25.54, p<0.001); referenced to the asymptomatic class, the odds ratio (OR) for BD by 
age 19 was 2.66 (95%CI 1.41-5.02) in the mildly symptomatic class and 7.1 in the highly 
symptomatic class (95% CI 3.32-15.11). The association between class membership and 
BD was 3.5-fold higher for females (OR=13.42, 95%CI 4.60-39.18) than males (OR=3.8, 
95% CI 1.29-11.22). 
Estimated Hazard Ratios (HR), referenced to the asymptomatic class, were 2.61 
(95% CI 1.40-4.87) for the mildly symptomatic class and 6.58 (95% CI 3.18-13.63) for the 
highly symptomatic class. ORs reflect the cumulative increase in the likelihood of BD 
while HRs reflect the increase in the incidence rate of BD in the mildly and highly 
symptomatic class.  The similarity between the ORs and the HRs might be partially 
explained by the small number of cases presenting with BD; yet it affirms the robustness 
of the association between class membership and risk for BD as it indicates that this 
association remains significant throughout the follow-up period. 
 




The lifetime prevalence of MDD, GAD and SA by age 19 years was 15.7% (n=248), 
4.0% (n=64) and 29.9% (n=473) respectively. As shown in Figure 3, class membership did 
not predict MDD (χ2=2.64, p=0.27) or GAD (χ2=3.05, p=0.22). Membership of the mildly, 
but not the highly, symptomatic class was associated with SA (χ2=12.40, p=0.05) 
although below the corrected statistical threshold. 
 
Alarm Symptoms for BD 
Parental endorsement of CBCL-MS items in the asymptomatic class was 
negligible. In the mildly symptomatic class, parents endorsed on average 5 CBCL-MS 
items but none with a probability higher than 0.1 (Figure 1). In contrast, the highly 
symptomatic class was characterized by a clustering of CBCL-MS items of hyperactivity, 
impulsivity, clowning, reduced sleep, mood lability and increased and loud speech that 
were endorsed with a probability of ≥ 0.3 (Figure 1) resulting in standardized CBCL-MS 
total score ≥70.  This score corresponds to the lower limit of the 95% CI for CBCL-MS 
scores of the highly symptomatic class.  
An important metric in considering this cluster as “alarm symptoms” is their 
positive and negative predictive value for BD. Positive predictive value (PPV) is the 
proportion of those with “alarm symptoms” who actually develop BD. Negative 
predictive value (NPV) is the proportion of those without “alarm symptoms” who do not 
develop BD. The PPV and NPV of the “alarm symptoms” identified here was 13.2% and 
96.3% respectively thus conforming to conventional values for “alarm symptoms in 






We show that it is possible to define subclinical manic symptoms in childhood 
that conform to the concept of “alarm symptoms” as they allow classification of 
individuals according to their risk of subsequent syndromal BD.  
 
Empirically derived classification based on degree and pattern of manic symptoms 
Consistent with previous reports we found that subclinical manic symptoms 
were common in childhood (Table 1) (11, 12).  The pattern and degree of these 
symptoms could be best explained by a 3-class model. In the asymptomatic class there 
was minimal parental endorsement of any CBCL-MS item. At the other end, the highly 
symptomatic class was characterized by parental endorsement of most CBCL-MS items 
with the highest probability of endorsement (≥0.3) observed for items reflecting 
hyperactivity, impulsivity, inattention, mood lability, increased volume and amount of 
speech and reduced sleep. Previous studies have also identified this clustering of 
symptoms as a dimension of subclinical manic states (29).  
A large proportion (27.2%) of children in the highly symptomatic class had 
childhood diagnoses of disruptive behavior disorders. This confirms previous reports 
that highly deviant subclinical manic states are associated with high rates of psychiatric 
disorders, particularly ADHD (29). It would appear that behavioral measures and risk 
factors, even when considered together, do not allow sufficient separation between 
ADHD and childhood antecedents of BD. This suggests that either the two disorders 
have overlapping pathophysiology or that measures with greater biological specificity 
are needed to differentiate them (30).    
 
Implications for the early detection of Bipolar Disorder  
Our results lend direct empirical support to the recent proposal by Post et al 
(2013)(31) that clinical features associated with high risk for BD could be used to 
formulate prevention strategies pending more detailed biological validation. The PPV 




The high NPV suggests that only about 3 out of 100 people without “alarm symptoms” 
will develop BD. Therefore in the absence of “alarm symptoms” subsequent BD is highly 
unlikely even when risk factors are present. The PPV of 13.2% suggests that about 13 
out of 100 individuals with “alarm symptoms” will develop BD. By way of comparison, 
the PPV of “alarm symptoms” for cancer in community samples usually ranges between 
2-10% (16, 32-34; Supplemental material). The PPV of any test depends on the 
prevalence of the disease in the population. Experience from oncology has shown that 
relatively low values are statistically inevitable when clinical features alone are used for 
disorders with low population prevalence (34).   It is therefore acknowledged that 
although “alarm symptoms” occur in the minority of patients who eventually develop 
cancer their presence requires further investigation. Acting on “alarm symptoms” for 
cancer has also been shown to assist in the early diagnosis of non-malignant disorders 
(35). Based on the UK primary care database, which holds information on 762325 
individuals aged 15 or older assessed between 1994-2000, for every 4-7 patients 
investigated for “alarm symptoms” for cancer one was found to have another non-
malignant but clinically important disorder requiring further intervention (35). A similar 
case could be made for the “alarm symptoms” for BD as identified here.  Although the 
presence of “alarm symptoms” for BD did not confer higher risk of MDD, GAD and SA, 
62 individuals (30%) presenting with “alarm symptoms” had such non-BD diagnoses by 
age 19.  This does not diminish the importance of “alarm symptoms” for BD but re-
enforcers their usefulness from a public health perspective. 
 
In the field of psychiatry we are beginning to engage in a public dialogue about 
the management of early signs of mental illness (36). “Alarm symptoms” as identified 
here are not diagnostic but allow the initiation of a meaningful discussion between 
parents and clinicians about further management. These initial steps would need to be 
formally evaluated in terms of effectiveness but in principle they should include 




minimization could focus on identifying and treating parental psychiatric disorders and 
improving family function.  
 
Methodological considerations  
 A particular strength of this study is the availability of data from a 
representative population sample of young where manic symptoms were captured 
contemporaneously and are free from recall or attribution biases. A further strength 
relates to case ascertainment which was not influenced by sampling biases associated 
with help-seeking behavior, impairment or symptom severity. Previous studies have 
shown that the severity of subclinical manic states is associated with greater functional 
impairment (12,13, 29) but there is little evidence to suggest that impairment is 
predictive of conversion (13). The prevalence of BD in this sample was consistent with 
that reported in other general population studies which support the generalizability of 
our findings (37). Although the CIDI is widely used, its structured format and 
administration by lay interviewers may limit the amount of information elicited. Data 
regarding syndromal conversion were available up to age 19 years. This could have led 
to an under-estimation of the PPV as the cohort had not yet passed the entire period of 
risk and it is possible that further cases of BD may present in the future. The scale used 
here does not allow us to comment on the contribution of episodicity. Episodicity is 
considered a salient clinical feature of BD particularly when assessing young people (38). 
It has been suggested that conversion to syndromal BD is increased in youth with 
episodic manic symptoms (39) but not in those with more chronic presentations (40). It 
is therefore possible that the addition of information of episodicity may further refine 
“alarm symptoms” for BD.  
 
Conclusions 
Our results provide support for the concept of “alarm symptoms”, symptoms that are 
associated with a subsequently greatly elevated risk of BD. More research using well- 
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Table 1. Frequency of endorsement of Child Behavioral Checklist-Mania Scale (CBCL-MS) at 
age 11 years 
CBCL –MS Items Frequency of Endorsement in the TRAILS 
(%) 
Inattentive or easily distracted 45.9 
Impulsive or acts without thinking 44.9 
Can’t sit still, restless or hyperactive 41.4 
Talks too much 39.5 
Feels others are out to get him/her  30.4 
Showing off or clowning 29.6 
Unusually loud 29.4 
Sudden changes in mood or feelings  27.7 
Teases a lot 26.0 
Sleeps less than most kids  23.6 
Trouble sleeping 15.6 
Gets in many fights 13.5 
Suspicious 13.4 
Thinks about sex too much 4.7 
Strange ideas  4.5 
Sees things that aren’t there  3.1 
Hears sound or voices that aren’t there 2.9 
Plays with own sex parts too much 2.6 




         
Table 2. Fit Indices for 1-5 Latent Class Solutions 
 BIC AIC SSA-BIC Entropy LMR  
p value 
1 Class 41063.10 40851.09 40942.38   
2 Classes 36194.22 35744.41 35936.89 0.83 <0.0001 
3 Classes 35402.25 34713.64 35008.30 0.84 <0.0001 
4 Classes 35396.68 34469.28 34866.12 0.80 0.002 
5 Classes 35519.03 34352.84 34851.85 0.76 0.76 






      
Table 3. Effect of covariates on class membership 
Asymptomatic vs. 
Mildly symptomatic 
Class   
Asymptomatic vs. 
Highly Symptomatic 
Class   
Mildly vs. Highly 
Symptomatic Class 
 
OR 95% CI p 
value 
OR 95% CI p 
value 









































































Supplemental Material  
A. Representativeness of the TRAILS sample 
The TRAILS cohort was identified through birth and school registers in the 5 northern 
municipalities of Holland. The TRAILS cohort was identified through birth and school 
registers. Recruitment was based on entire schools participating; 91% of all the 
schools in the municipalities agreed to take part.  Data collection began when 
participants were aged 11 years. According to the TRAILS data collection protocol, 
information was obtained on participants’ general intellectual ability, parental 
socioeconomic status and psychiatric morbidity and family functioning. Behavioral 
assessments were undertaken at age 11, 13 and 16 years and formal lifetime 
psychiatric diagnoses were ascertained at age 19 years.  All data were anonymised 
by TNS NIPO (www.tns-nipo.com), a custom research company. Table S1 shows that 
key variables regarding representativeness of the TRAILS cohort are comparable to 
those from the 2001 Dutch national census. 
 
Table S1. Characteristics of TRAILS participants at enrolment compared to the 
2001 national census data available online from the Centraal Bureau voor de 
Statistiek (www.cbs.nl) 
 TRAILS  2001 Dutch Census  
% Girls 50.8% 48.8%1 
% White European 89.4% 93.2%1 
Lower parental education2 32.6% 30.6% 
% children living with both parents3 84.5% 84% 
Median disposable household income  21780 Euros 20700 Euros 
1 The census reported on the 10-15 years age range; 2Defined as having completed up to lower half of secondary school;  




B. Development of the Child Behaviour Checklist-Mania Scale (full details in 
Papachristou et al. PloSONE 2013) 
We followed a typical content validity procedure (Grant & Davis, 1997; Lengua et al, 
2001) which involves content experts who judge each item of an instrument against 
the definition of the domains intended to measure and score its relevance on a 4-
point scale ranging from 1 (irrelevant) to 4 (highly relevant). In our study, content 
validity was assessed by a panel of 10 qualified child and adolescent psychiatrists 




These experts were representative of the professional settings (inpatient, outpatient, 
academic) within the South London and Maudsley NHS Foundation Trust. They rated 
the relevance of each item from the total item pool of the CBCL 6-18 on a scale of 1-
4 against each of the symptom domains that correspond to operational criteria for 
mania of both the Diagnostic Statistical Manual for Mental Disorders (www.dsm-
5.org) and the International Classification of Diseases 
(www.who.int/classifications/icd). In addition, the panel considered CBCL items 
relating to psychotic-like experiences as childhood and adolescent. Our decision was 
largely based on data suggesting that psychotic symptoms are strongly associated 
with BD (OR=14.8; 95%CI 8.7-25.2) (van Os et al., 2000) and that psychosis prone 
individuals are much more likely (29% vs 5%) to develop BD (Verdoux & van Os, 
2002).  The content validity index (CVI) for each item was established by calculating 
the proportion of experts scored it as relevant (score 3) or highly relevant (score 4) 
for any of the domains. A minimum item CVI of 0.80 (Grant & Davis, 1997) was 
required for inclusion in the second stage where final item inclusion to the CBCL-MS 
was based on unanimous agreement. Following consensus meetings, 19 items were 
selected for inclusion in the CBCL- Mania Scale (CBCL-MS) (Supplemental Table S2). 
The scoring of the CBCL-MS at each assessment age was based on summing the 
scores of each of the 19 individual items. Scores were then standardized (T scores) 
following the scoring procedure recommended by Achenbach and Rescorla (2001) 
using the TRAILS data as the standardization sample. Standardization of the CBCL 
scores for the CBCL-MS, as well as for other CBCL-based syndrome scales, was 














Table S2. Child Behavior Checklist-Mania Scale items and corresponding core and extended 
criteria for Mania 
CBCL Items DSM criteria for Mania 
Core Symptoms 
37. Gets in many fights 
87. Sudden changes in mood or feelings  
96. Thinks about sex too much 
A distinct period of abnormally and persistently 
elevated, expansive or irritable mood 
74. Showing off or clowning 
94. Teases a lot 
Inflated self-esteem or grandiosity 
76. Sleeps less than most kids  
100. Trouble sleeping 
Decreased need for sleep (e.g., feels rested after 
only 3 hours of sleep) 
93. Talks too much 
104. Unusually loud 
More talkative than usual or pressure to keep 
talking  
Flight of ideas or subjective experience that 
thoughts are racing 
78. Inattentive or easily distracted Distractibility (i.e., attention too easily drawn to 
unimportant or irrelevant external stimuli) 
10. Can’t sit still, restless or hyperactive 
60. Plays with own sex parts too much 
Increase in goal-directed activity (at work, at 
school, or sexually) or psychomotor agitation 
41. Impulsive or acts without thinking  
59. Plays with own sex parts in public 
 
Excessive involvement in pleasurable activities 
that have a high potential for painful 
consequences (e.g., engaging in unrestrained 
buying sprees, sexual indiscretions, or foolish 
business investments) 
Extended Symptoms 
34. Feels others are out to get him/her  
85. Strange ideas  
89.Suspicious 
Delusions 
40. Hears sound or voices that aren’t 
there 
70. Sees things that aren’t there  
Hallucinations 









Reliability analysis demonstrated high internal consistency for the 19 items of the 
CBCL-MS at all assessment ages (Cronbach’s alpha≥80; total item correlation >0.37). 
Based on Receiver Operator Curve (ROC) analysis on the CBCL-MS data the area 
under the curve (AUC) was 0.64 (p<0.01) which represents a satisfactory 
performance for a general population sample. A forward stepwise logistic regression 
model showed that the CBCL-MS had significantly increased ability to predict BD 
compared to the CBCL-Pediatric Bipolar Disorder scale (Wald χ2= 12.69, p<.001) and 
the CBCL-Externalizing Scale (Wald χ2= 3.47, p=.05). 
 
C. Details of Parental Morbidity in the TRAILS Sample  
Table S3. Parental Psychiatric Morbidity in the TRAILS sample 
Diagnosis Percentage  (%) of children in the TRAILS sample per parental 
diagnosis 
 Paternal Maternal 






















D. Characteristics of patients with Bipolar Disorder per class  
 
Table S4. Characteristics of cases with syndromal BD by age 19 according to class 
membership at age 11 






BD cases arising 










% of all cases with Bipolar Disorder in the 
TRAILS sample 
16.2 38.37 17.4 
Male: Female
a
 1.0:1.0 1.0:0.7 1.0:1.1 
% High SESb 35.3 52.9 11.8 
IQc 98.29 (14.06) 95.18 (12.30) 97.40 (14.25) 
% Parental Psychiatric Morbidity
d
 15.6 53.1 31.2 
Age of Onset of BD (years)e 15.57 (2.06) 15.45 (2.33) 15.67 (2.22) 




11.8 52.9 35.3 
Continuous data are presented as mean (standard deviation); Categorical data are presented as proportions (%) across classes; 
aχ2=0.57, p=0.75; bχ2=3.84, p=0.43 cF(2,59)=0.33,p=0.72;
 dχ2=2.78, p=0.25; eF(2,59)=0.05, p=0.95; 






E. Positive Predictive Value of “Alarm Symptoms” for Cancer  
Table S5. Positive Predictive Value of “Alarm Symptoms” for Cancer 
Alarm Symptoms Positive Predictive Value 
 
Rectal examination for prostate malignacy1 12% 
Hematuria for urological cancer2,3 7-10% 
Fecal occult blood for colon cancer1, 3 2-6% 
Dysphagia for gastrointestinal cancer2,3 2-7% 
Hemoptysis for lung cancer3,4 5-7% 
Concomitant presence of haemoptysis, loss of 
weight, loss of appetite, dyspnoea, thoracic pain, 
fatigue and cough for lung cancer4 
10% 
Values cited are averages or pooled estimates from primary care or community samples; 1 Shapley et al. Br J Gen Pract 2010; 
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6   Trajectories to Bipolar Disorder from Childhood to Adulthood 
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Importance: There are unresolved questions regarding the early natural history of 
Bipolar Disorder (BD). Prospective longitudinal studies are needed to determine the 
dynamic course of subclinical manic states and their predictive validity for syndromal 
onset of BD.  
Objectives: To chart the trajectories of subclinical manic states throughout 
adolescence and their relationship to conversion to syndromal BD.  
Design: Prospective multi-wave 8-year follow-up study 
Setting: European general population cohort  
Participants: Participants of the TRacking Adolescents’ Individual Lives Survey 
(TRAILS) assessed at baseline aged 11 years (n=2230) and then at age 13 (n=2149), 
16 (n=1816) and 19 years (n=1881). 
Main Outcomes and Measures: Growth Curve Model estimated trajectories of 
subclinical manic states for TRAILS participants classified as asymptomatic, mildly 
symptomatic and highly symptomatic based on their score on the Child Behaviour 
Checklist-Mania Scale at age 11. Lifetime diagnoses of BD by age 19 years were 
ascertained using the Composite International Diagnostic Interview. 
Results: In the asymptomatic class, both converters and non-converters showed an 
increase in CBCL-MS total and factor scores between assessment wave 1 and 3. The 
mean change and the mean rate of change were greater for converters. In the mildly 
symptomatic class both converters and non-converters followed similar trajectories 
of decreasing in CBCL-MS scores. In the highly symptomatic class, the trajectories of 
converters and non-converters diverged significantly. Non-converters showed 
progressive decrease in psychopathology while converters evidenced persistence 
(but no exacerbation) of subclinical manic symptoms. We found no evidence of 





Conclusions and relevance: Our findings reconcile previous conflicting views 
regarding the early natural history of BD and suggest that the degree and pattern of 






The diagnosis and clinical subtyping of Bipolar Disorder (BD) depend on the 
severity and duration of manic symptoms. Adolescence and young adulthood are 
peak periods of risk for the syndromal onset of BD. 1-3 Therefore there is much 
clinical and public health interest in the predictive value of subclinical manic 
symptoms in youth as they may signal the onset of syndromal BD.   
Careful follow-back studies clearly indicate that the majority (up to 50%) of 
patients with BD report subclinical symptoms that predate syndromal onset by an 
average of 7 years. 4-11  Approximately 70% of patients experience subclinical manic 
symptoms of elation/irritability, reduced sleep, impulsivity and increased speech.6-11 
Depressive symptoms are also common but less prevalent. 6-11 Follow-up studies of 
offspring of BD offer a prospective evaluation of the temporal evolution of 
subclinical symptoms preceding and leading to the onset of BD.12-15 These studies 
describe premorbid depressive and anxious symptomatology in the early childhood 
of high-risk individuals. 12-15 In those later developed BD manic symptoms become 
more clearly defined during adolescence. 13,14 Taken together this evidence has been 
used to argue that subclinical manic symptoms may define prodrome-like mental 
state for BD. 16-18 At the same time it is acknowledged that recall and attribution 
biases or the presence of parental disorder pose significant limitations and 
challenges to the generalisation of retrospective and high risk studies. 16,17  
Prospective examination of general population samples of youth are particularly 
useful in addressing these concerns. Informative studies that used repeated 
assessments over follow-up periods of 10-16 years are the Oregon Adolescent 
Depression Project, 19 the Dunedin Multidisciplinary Health and Development Study 
(Kim-Cohen et al. 2003),20 and the Early Developmental Stages of Psychopathology 
study. 21-23 These studies demonstrate that manic symptoms, particularly during 
adolescence, in the general population are both highly prevalent and weakly 
predictive of clinical outcomes.  19-23 At any time, about 40% of youth may express at 
least one and approximately 10% may manifest more than 7 manic symptoms. 21-23 A 




that it is possible to enhance the predictive validity of manic symptoms by focusing 
on the profile (number, type and severity) of manic symptoms in childhood. 24 
 We used data from the TRacking Adolescents’ Individual Lives Survey (TRAILS) 
(www.trails.nl), a four-wave study of a representative cohort of 2230 Dutch children 
born between 1 October 1989 and 30 September 1991 in the northern 
Netherlands.25-27 Participants were first assessed at age 11 years (wave-1) and then 
at age 13, 16 and 19 years. We used the Child Behaviour Checklist-Mania Scale 
(CBCL-MS) (details in Supplement), 28 which records parental endorsement of 19 
manic behaviours, to define subclinical manic states from childhood (wave-1) to 
adolescence (wave-3). At age 11, manic symptoms clustered in four factors 
corresponding to distractibility/disinhibition, psychosis, increased libido and 
disrupted sleep (Figure 1).  It is important to note that this factor structure remained 
very stable over the three assessment waves (details in Supplement).28 Using the 
CBCL-MS symptom profile at age 11 latent class analysis stratified the TRAILS sample 
into an asymptomatic, mildly symptomatic and highly symptomatic class (Table 1). 24 
The lifetime prevalence of broadly defined BD by age 19 years in each class was 
2.1%, 5.4% and 13.2% respectively. Compared to the asymptomatic class, the odds 
ratios for future BD in the mildly and highly symptomatic classes were 2.7 (95% CI 
1.41-5.01) and 7.1 (95% CI 3.31-15.11) respectively. The positive and negative 
predictive value of class membership was 13.2% and 96.3% respectively. These 
results established that subclinical manic states in childhood are predictive of future 
risk for BD. 24,28  
The present analysis examines the trajectories of subclinical manic states, 
captured by the CBCL-MS, throughout the period of adolescence for individuals in 
each class. In addition to the total CBCL- MS score, we also examine longitudinal 
change in the factors of distractibility/inattention, psychosis, increased libido and 
disrupted sleep as these dimensions of subclinical manic states may follow different 
trajectories. We test whether longitudinal changes in subclinical manic states or 
specific symptom dimensions can differentiate TRAILS participants who convert to 






Participants and Procedures 
Details of the TRAILS design, sampling and assessments have been published 
elsewhere 25-27 and are summarised in the Supplement and eTable 1. The cohort 
comprises 2230 individuals born in the northern Netherlands between 1 October 
1989 and 30 September 1991. Cohort members were assessed at baseline when 
aged 11 years (n=2230) and then at age 13 (n=2149), 16 (n=1816) and 19 years 
(n=1881). The retention rate over the 8 year follow-up period was 84.3% which is 
high for longitudinal studies of psychiatric outcomes. 25,26 Behavioral assessments 
were undertaken at age 11, 13 and 16 years and formal lifetime psychiatric 
diagnoses were ascertained at age 19 years. TRAILS members lost due to attrition at 
age 19 were predominantly males from a lower socioeconomic background 
(p<0.001) but did not differ in terms of family functioning (p=0.15) or parental 
psychiatric history (p=0.22) from those who participated at baseline. 23 Ethical 
approval was granted by the Dutch Central Committee on Research Involving Human 
Subjects and permission to use anonymised data from the TRAILS was granted by the 
study management committee. 
Behavioral assessments at age 11, 13, and 16 years were based on the Child 
Behavioral Checklist-Mania Scale (CBCL-MS).27 The scale records parental 
endorsement of 19 items capturing the presence of subclinical manic symptoms over 
the previous 6 months (see eTable 2).  Reliability analysis demonstrated high internal 
consistency for the 19 items of the CBCL-MS (Cronbach’s alpha≥80; total item 
correlation >0.37). Principal component analyses (PCA) of the CBCL-MS data at ages 
11, 13 and 16 years resulted in an almost identical factor structure and explained 
48.18%, 46.06% and 44.94% of the variance of the items respectively. The four 
factors corresponded to: (1) distractibility/ disinhibition (2) psychosis (3) increased 
libido (4) disrupted sleep (details in Supplement and eTables3-4). Confirmatory 
Factor Analyses established good fit of the data; Root Mean Square Error of 
Approximation values were 0.04, 0.04 and 0.05, and Confirmatory Fit index values 




At age 19, lifetime diagnoses of TRAILS participants were ascertained using the 
Computer Assisted Personal Interview, version 20, of the Composite International 
Diagnostic Interview (CIDI) (www.hcp.med.harvard.edu/wmhcidi). Diagnostic 
assessments were conducted blind to participants CBCL scores. In this study, we 
considered lifetime diagnoses of broadly defined Bipolar Disorder to encompass BDI, 
BDII, mania and hypomania. The CIDI has high test-retest reliability for the diagnosis 
of BDI 28 as well as excellent concordance rates with the Structured Clinical Interview 
for DSM-IV (SCID) for lifetime BDII and hypomania. 29 
Classification of TRAILS participants based on the CBCL-MS at age 11 years 
As we have previously reported 23 latent class analysis of the CBCL-MS total score 
at age 11 year identified three classes of TRAILS participants as shown in Table 1 
(also eTable 6). The probability of parental endorsement of CBCL-MS items at age 11 
for each class is shown at Table 2.  In the asymptomatic class there was minimal 
parental endorsement of any CBCL-MS item. In the mildly symptomatic class, parents 
endorsed on average 5 symptoms but none with a probability of more than 0.1 By 
contrast, parents in the highly symptomatic class endorsed on average 10 symptoms. 
The highest probability of endorsement (≥0.3) was observed for items reflecting 
hyperactivity, impulsivity, inattention, mood lability, increased volume and amount 
of speech and reduced sleep. 
TRAILS participants in the highly symptomatic class were significantly more likely 
to have lower IQ, lower parental SES, greater family dysfunction and positive 
parental psychiatric morbidity compared to the other two classes (Table 1). Class 
membership at age 11 was significantly associated with subsequent diagnosis of BD 
(χ2=25.54, p<0.001) but not of depression, anxiety or substance abuse disorder 
(p>0.05); referenced to the asymptomatic class, the odds ratio for BD by age 19 was 
2.66 (95%CI 1.41-5.02) in the mildly symptomatic class and 7.1 in the highly 
symptomatic class (95% CI 3.32-15.11). Of the 69 TRAILS participants who converted 
to syndromal BD between 12 and 19 years, 14 (1.6%) derived from the asymptomatic 
class, 33 (3.9%) from the mildly symptomatic class and 15 (7.5%) from the highly 





Within each class, Growth Curve Models (GCMs) were fitted to examine potential 
differences in the longitudinal evolution of CBCL-MS total and factor scores between 
youths who converted to BD by age 19 years and those who did not. Since 
conversion to BD could have occurred at any time during the 8-year follow-up 
period, missing values to CBCL-MS scores were assigned for future assessments of 
those participants who converted to BD between assessment waves. These 
participants were compared with the remaining participants for differences in their 
CBCL-MS scores in the assessments preceding onset. As all tests examining these 
differences yielded non-significant results (all p values>0.05), the assigned missing 
data were assumed to be missing Completely at Random (MCAR). Under the MCAR 
assumption, we used full information maximum likelihood to estimate the 
trajectories of all cases across the three assessment waves conditional on observed 
trajectories. 
For each model, goodness of fit was determined based on the normed chi square 
and the comparative fit index, which are considered less sensitive to sample size. 30,31 
The normed chi square (χ2 divided by the degrees of freedom of the model) tests the 
hypothesis the covariance matrix predicted by the model does not differ from the 
observed covariance matrix.  Therefore the model is acceptable if the normed χ2 is 
less than 5. 32 The Comparative Fit Index (CFI) compares the fit of the covariance 
matrix predicted by the model to an independent model which assumes that the 
variables are uncorrelated.  The predicted model is considered acceptable if the CFI 
exceeds 0.90. 30 Given an acceptable model fit, we considered the models’ intercept, 
which represents CBCL-MS total or factor scores at baseline, and slope, which 
represents the rate of change across assessment waves. Positive or negative slope 
values respectively reflect increases or decreases in the rate of change. Significant 
values (p<0.05) for the slope indicate the presence of intra-individual change over 
time. Significant p values (p<0.05) for the variance estimates of the intercept and 
slope, indicate significant inter-individual differences in baseline and rate of change 
over time. 
 Since the interval between the last CBCL-MS assessment and syndromal 




restricted to cases who had converted within 1 year of their last behavioral 
assessment irrespective of class. This allowed us to comment on whether there were 
significant changes in CBCL-MS total or factor scores proximal to disease onset.   
 Analyses were performed using MPlus 6.0 (www.statmodel.com) and IBM SPSS 
Statistics, Version 19 (www.spss.com).  
 
Results 
 For all models tested, the normed chi-square was < 3.97 and the CFI was > 0.93 
suggesting good model fit. Threshold for statistical inference was set at p <0.001. We 
focus on changes in the CBCL-MS total score. Results for the CBCL-MS factor scores 
will be presented only when they differed from those of the total score.  
 
Asymptomatic Class 
 For the non-converters, the mean intercept for the CBCL-MS total score was 42.13 
(p<0.001). The mean slope was 1.85 (p<0.001); the mean slope having a positive 
value is consistent with increased intra-individual CBCL-MS score over time. On 
average, the increase was 3.7 points between assessment waves 1-3 (Figure 2). The 
variance of the intercept and the slope were also significant indicating significant 
inter-individual variability. Analysis of the CBCL-MS factor scores showed that they 
followed the same direction and pattern as the CBCL-MS total score.   
 For converters, the mean intercept of the CBCL-MS total score was 42.4(p<0.001). 
The mean slope was 3.14 (p=0.004) indicating significant intra-individual increase 
over time.  On average, the increase in the CBCL-MS total score was 6.2 points 
between assessment waves 1-3 (Figure 2). The variance of the intercept and slope 
was not significant indicating minimal inter-individual variability.  
 
Mildly Symptomatic Class 
 For non-converters, the mean intercept and slope values for the CBCL-MS total 
score were 52.95 (p<0.001) and -0.63 (p=0.002) respectively. The negative slope 




average, the CBCL-MS total score decreased by 1.2 points between assessment 
waves 1-3. The variance estimates for the mean intercept was significant for the 
CBCL-MS total and factor scores. The variance estimates for the slope was significant 
for the CBCL-MS total and the Distraction/Disinhibition factor score but not for the 
remaining CBCL-MS factor scores (all p>0.12).  
 For converters, the mean intercept and the mean slope values for the CBCL-MS 
total scores were 54.87 (p<0.001) and -2.67 (p<0.001) respectively. On average, the 
CBCL-MS total scores decreased by 5.3 points between assessment waves 1-3 (Figure 
2). The variance estimates for the intercept was also significant. The variance 
estimates for the slope was significant for the CBCL-MS total and the 
Distraction/Disinhibition factor score but not for the remaining CBCL-MS factor 
scores (all p>0.46). 
 The mean slopes of non-converters and converters were not significantly different 
suggesting that the trajectories of the two groups were comparable.  
 
Highly Symptomatic Class 
 For non-converters, the mean intercept and slope of the CBCL-MS total score 
were 71.07 (p<0.001) and -3.45 (p<0.001).  Non-converters showed an average 
decrease of 6.9 points between assessment waves 1-3 (Figure 2). The variance of the 
intercept and slope were not significant for the CBCL-MS total score. For the 
Psychosis and Disrupted Sleep factors, the mean and variance of the intercepts were 
significant but the slopes were not.   
 For converters, the mean intercept of the CBCL-MS total score was 72.49 
(p<0.001). However the mean slope was not significant (p=0.33) indicating minimal 
change over time. The same pattern for mean intercepts and slopes was observed 
for the CBCL-MS factor scores; none of the slopes were significant (p>0.32).   
 The mean slopes of non-converters and converters were significant suggesting 
that non-converters had a different trajectory marked by decreasing 
psychopathology while no change was noticeable for converters.  
   




 In order to control for the variable interval between age at the last behavioral 
assessment and age at syndromal onset of BD we conducted an additional GCM 
examining the trajectories of CBCL-MS scores for participants (n=20) who were 
diagnosed with syndromal BD, irrespective of class, within a year of their last 
behavioral assessment. Model fit to the data was excellent (normed chi-square=0.44, 
CFI>0.95). The mean intercept and variance of the intercept were both significant, 
indicating inter-individual heterogeneity.  However, the slope was not significant 
(p=0.80) suggesting that mean CBCL-MS score did not change significantly in the year 
preceding onset compared to previous scores.    
 
Discussion 
 Using prospective repeated CBCL-MS data from the TRAILS population cohort we 
charted the trajectories of subclinical manic states from age 11 to age 16 years. 
TRAILS participants at age 11 were classified according to their CBCL-MS profile to an 
asymptomatic, mildly symptomatic or highly symptomatic class. Our key objective 
was to determine whether longitudinal changes in subclinical manic states or specific 
symptom dimensions can differentiate TRAILS participants who convert to BD by age 
19 years (converters) from those who do not (non-converters) within each class. 
 We found that the CBCL-MS profile at age 11 years was a significant determinant 
of subsequent longitudinal change between converters and non-converters. In the 
asymptomatic class, both converters and non-converters showed an increase in 
CBCL-MS total and factor scores between assessment wave 1 and 3. The mean 
change and the mean rate of change were greater for converters. In the mildly 
symptomatic class both converters and non-converters followed similar trajectories 
of decrease in CBCL-MS scores. In the highly symptomatic class, the trajectories of 
converters and non-converters diverged significantly. Non-converters showed 
progressive decrease in psychopathology while converters evidenced persistence 
(but no exacerbation) of subclinical manic symptoms.  
The results from the highly symptomatic group accord with previous observations by 
Tijssen et al (2010) who rated manic symptoms over an average of 8 years in a 




around Munich, Germany. 21 In their study, individuals having two or more manic 
symptoms in more than one assessment had a higher risk of conversion to 
syndromal BD; the odd ratio for conversion increased with the number of symptoms 
and the degree of persistence. However, our data suggest that those who were 
asymptomatic in childhood but later convert to BD show a significant increase in 
hypomanic symptoms. For those with mild childhood psychopathology conversion to 
syndromal BD was not linked to differential changes in subclinical manic states 
compared to those who did not. If anything, conversion seems to occur despite a 
pre-onset improvement in CBCL-MS scores. Clear definable persistence in symptom 
ratings was only seen in the highly symptomatic class where it was associated with 
conversion while significant symptomatic improvement was observed in non-
converters.  
 These results seem to reconcile divergent views with regards to the early natural 
course of BD. Studies of children referred to psychiatric services and diagnosed with 
“mood dysregulation” or with atypical BD suggest that manic symptoms are present 
from childhood and persist as children become older. 33, 34 These clinical populations 
are also enriched in risk factors for BD particularly cognitive dysfunction and parental 
psychiatric morbidity. 33,34  We suggest that the converters in the highly symptomatic 
group conform to the pattern described above.  
 Patients with BD often recall having subclinical manic symptoms for many years 
prior to the onset of BD. 4-11 The description is commonly of gradually increasing 
psychopathology over 6-8 years. 4,7 We propose that converters in the asymptomatic 
group are likely to conform to the pattern described above. The level of subclinical 
manic symptoms although increasing between assessment waves it still quite low 
and within normal variation. This may also explain the difficulty in identifying these 
symptoms as indicative of pathology and the delays in recognising the disorder. 4,7 
In the mildly symptomatic group conversion occurred despite overall reduction in 
psychopathology over time. It is worth noting that parents of children in this class 
endorsed few CBCL-MS item (average of 5) with no evidence of clustering (Table 2). 
It is also worth noting that proportionally more cases of BD occurred in this group 




other epidemiological studies that have reported increased risk for BD in adolescents 
that seem well-adjusted and have above average academic performance during the 
premorbid phase of their illness.  
 None of the analyses conducted suggests that BD is preceded by a district and 
definable worsening of subclinical manic symptoms that could reliably differentiate 
converters from non-converters.   
 This study has several strengths, primarily the availability of prospective data on 
subclinical manic states spanning the entire period of adolescence from a 
representative population sample of youth. 36 Additionally, assessment of manic 
symptoms was not influenced by recall or attribution and case ascertainment was 
not biased by help-seeking behavior, impairment or symptom severity. The 
prevalence of BD in this sample was consistent with that reported in other 
population studies.  The use of the CIDI may have limited the amount of information 
elicited which has the potential of missing more mild syndromal presentations. As 
the TRAILS cohort is still going through the period of risk for syndromal conversion 
further cases of BD may present in the future. The CBCL-MS does not record 
information about episodicity considered by many a salient predictor of syndromal 
BD in youth. 33 We did not consider the potential contribution of depressive 
symptoms in any of our models. However, in this sample only 6 out of the 69 
individuals that presented by BD had had a previous diagnosis of depression.  
In conclusion, the findings of this study reconcile previous conflicting views regarding 
the early natural history of BD and suggest that the degree and pattern of childhood 
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Table 1. Characteristics of TRAILS members and BD cases  according to class membership at age 11 
 Asymptomatic Class 
(N=862) 




Total TRAILS Sample 
Sex (% Male) 39.7 54.0 67.8 
CBCL-MS Scores at age 11 42.06(2.73) 53.01(4.80) 71.40(7.34) 
Distractibility/Disinhibition 
Factor Scores at age 11 
41.92(2.55) 53.23(5.15) 71.03(6.65) 
Psychosis Factor Scores at 
age 11 
45.83(4.66) 51.07(8.85) 63.70(15.78)) 
Disrupted Sleep Factor 
Scores at age 11 
47.33(6.43) 51.11(10.86) 56.44(13.92) 
Increased Libido  Factor 
Scores at age 11 
48.91(8.06) 49.79(7.83) 56.04(20.01) 
Mean Number of 
symptoms 
1.36(1.15) 5.76(1.89) 10.37(2.07) 
Family Function 1.68(0.35) 1.82(0.33) 1.97(0.35) 
IQ 101.13(14.16) 96.93(14.67) 92.02(13.63) 
% Positive Parental 
Psychiatric Morbidity 
36.9 48.5 65.8 
% High SES 35.5 19.8 11.6 
% Positive History of 
Disruptive Behavior 
Disorders prior to Age 11a 
4.19 11.03 27.19 
% Positive History of any 
Psychiatric Diagnoses 
prior to Age 11
b
 
5.54 13.31 29.82 
BD Cases Arising from each Class 
Number (N) 14 33 15 
Age of Onset 15.57(2.06) 15.45(2.33) 15.67(2.23) 
Sex (% Male) 50 57.6 46.7 
CBCL-MS Scores at age 11 42.41(2.08) 54.79(5.44) 72.49(10.20) 
Distractibility/Disinhibition 
Factor Scores at age 11 
42.22(1.92) 54.41(4.56) 70.36(7.30) 
Psychosis Factor Scores at 
age 11 
47.18(4.77) 52.19(8.91) 69.38(21.39) 
Disrupted Sleep Factor 
Scores at age 11 
46.59(5.90) 53.67(13.57) 58.68(16.25) 
Increased Libido  Factor 
Scores at age 11 
48.31(0.00) 50.53(12.75) 53.20(18.91) 
Mean Number of 
symptoms 
1.5(0.85) 6.36 (2.09) 10.87(3.02) 
Family Function 1.77(0.28) 1.87(0.38) 1.97(0.34) 
IQ 98.29(14.06) 95.18(14.24) 97.40(14.25) 
% Parental Psychiatric 
Morbidity 
35.7 51.5 66.7 
% High SES 42.9 27.3 13.3 
% Positive History of 
Disruptive Behavior 
Disorders prior to Age 11 a 
14.29 27.27 40.0 
% Positive History of any 
Psychiatric Diagnoses 
prior to Age 11
b
 
14.29 30.30 40.0 
Continuous data are presented as mean (standard deviation); Categorical data are presented as proportions (%) within classes; 




Table 2. Probability of parental endorsement of CBCL-MS items per class 









Inattentive or easily distracted 0.01 0.10 0.61 
Can’t sit still, restless or hyperactive 0.00 0.10 0.55 
Impulsive or acts without thinking 0.00 0.04 0.49 
Unusually loud 0.00 0.01 0.42 
Talks too much 0.00 0.08 0.41 
Showing off or clowning 0.00 0.01 0.32 
Sudden changes in mood or feelings  0.00 0.02 0.22 
Teases a lot 0.00 0.01 0.15 
Gets in many fights 0.00 0.00 0.08 
Thinks about sex too much 0.00 0.00 0.04 
Feels others are out to get him/her  0.01 0.04 0.20 
Suspicious 0.00 0.01 0.11 
Strange ideas  0.00 0.00 0.03 
Sees things that aren’t there  0.00 0.00 0.02 
Hears sound or voices that aren’t 
there 
0.00 0.00 0.01 
Sleeps less than most kids  0.02 0.09 0.19 
Trouble sleeping 0.01 0.07 0.16 
Plays with own sex parts too much 0.00 0.00 0.01 








































































Supplemental Material  
Representativeness of the TRAILS sample 
The TRAILS cohort was identified through birth and school registers in the 5 northern 
municipalities of Holland. Recruitment was based on entire schools participating; 
91% of all the schools in the municipalities agreed to take part. Table S1 shows that 
key variables regarding representativeness of the TRAILS cohort are comparable to 
those from the 2001 Dutch national census. 
 
Table S1. Characteristics of TRAILS participants at enrolment compared to the 2001 
national census data available online from the Centraal Bureau voor de Statistiek 
(www.cbs.nl) 
 TRAILS  2001 Dutch Census  
% Girls 50.8% 48.8%1 
% White European 89.4% 93.2%1 
Lower parental education2 32.6% 30.6% 
% children living with both parents3 84.5% 84% 
Median disposable household income  21780 Euros 20700 Euros 
1 The census reported on the 10-15 years age range; 2Defined as having completed 
up to lower half of secondary school 2 includes married and cohabiting couples 
 
Development of the Child Behaviour Checklist-Mania Scale (full details in 
Papachristou et al. PloSONE 2013) 
We followed a typical content validity procedure (Grant & Davis, 1997; Lengua et al, 
2001) which involves content experts who judge each item of an instrument against 
the definition of the domains intended to measure and score its relevance on a 4-
point scale ranging from 1 (irrelevant) to 4 (highly relevant). In our study, content 
validity was assessed by a panel of 10 qualified child and adolescent psychiatrists 
(average number of years of clinical and research experience: 8; range: 4—20 years). 
These experts were representative of the professional settings (inpatient, outpatient, 
academic) within the South London and Maudsley NHS Foundation Trust. They rated 
the relevance of each item from the total item pool of the CBCL 6-18 on a scale of 1-
4 against each of the symptom domains that correspond to operational criteria for 
mania of both the Diagnostic Statistical Manual for Mental Disorders (www.dsm-




(www.who.int/classifications/icd). In addition, the panel considered CBCL items 
relating to psychotic-like experiences as childhood and adolescent. Our decision was 
largely based on data suggesting that psychotic symptoms are strongly associated 
with BD (OR=14.8; 95%CI 8.7-25.2) (van Os et al., 2000) and that psychosis prone 
individuals are much more likely (29% vs 5%) to develop BD (Verdoux & van Os, 
2002).  The content validity index (CVI) for each item was established by calculating 
the proportion of experts scored it as relevant (score 3) or highly relevant (score 4) 
for any of the domains. A minimum item CVI of 0.80 (Grant & Davis, 1997) was 
required for inclusion in the second stage where final item inclusion to the CBCL-MS 
was based on unanimous agreement. Following consensus meetings, 19 items were 
selected for inclusion in the CBCL- Mania Scale (CBCL-MS) (Supplemental Table S2). 
The scoring of the CBCL-MS at each assessment age was based on summing the 
scores of each of the 19 individual items. Scores were then standardized (T scores) 
following the scoring procedure recommended by Achenbach and Rescorla (2001) 
using the TRAILS data as the standardization sample. Standardization of the CBCL 
scores for the CBCL-MS, as well as for other CBCL-based syndrome scales, was 




















Table S2. Child Behavior Checklist-Mania Scale items and corresponding core and 
extended criteria for Mania  
CBCL Items DSM-IV criteria for Mania 
Core Symptoms 
37. Gets in many fights 
87. Sudden changes in mood or 
feelings  
96. Thinks about sex too much 
A distinct period of abnormally and 
persistently elevated, expansive or 
irritable mood 
74. Showing off or clowning 
94. Teases a lot 
Inflated self-esteem or grandiosity 
76. Sleeps less than most kids  
100. Trouble sleeping 
Decreased need for sleep (e.g., feels 
rested after only 3 hours of sleep) 
93. Talks too much 
104. Unusually loud 
More talkative than usual or pressure to 
keep talking  
Flight of ideas or subjective experience 
that thoughts are racing 
78. Inattentive or easily 
distracted 
Distractibility (i.e., attention too easily 
drawn to unimportant or irrelevant 
external stimuli) 
10. Can’t sit still, restless or 
hyperactive 
60. Plays with own sex parts too 
much 
Increase in goal-directed activity (at work, 
at school, or sexually) or psychomotor 
agitation 
41. Impulsive or acts without 
thinking  
59. Plays with own sex parts in 
public 
 
Excessive involvement in pleasurable 
activities that have a high potential for 
painful consequences (e.g., engaging in 
unrestrained buying sprees, sexual 
indiscretions, or foolish business 
investments) 
Extended Symptoms 
34. Feels others are out to get 
him/her  
85. Strange ideas  
89.Suspicious 
Delusions 
40. Hears sound or voices that 
aren’t there 
70. Sees things that aren’t there  
Hallucinations 
Items numbered as in the Child Behaviour Checklist (6/18) 
 
Psychometric Properties and Discriminative value of the Child Behaviour Checklist-
Mania Scale 
Reliability analysis demonstrated high internal consistency for the 19 items of the 




Based on Receiver Operator Curve (ROC) analysis on the CBCL-MS data the area 
under the curve (AUC) was 0.64 (p<0.01) which represents a satisfactory 
performance for a general population sample. A forward stepwise logistic regression 
model showed that the CBCL-MS had significantly increased ability to predict BD 
compared to the CBCL-Pediatric Bipolar Disorder scale (Wald χ2= 12.69, p<.001) and 
the CBCL-Externalizing Scale (Wald χ2= 3.47, p=.05). 
Reliability analyses demonstrated high internal consistency for the 19 items of the 
CBCL-MS at all assessment ages (Cronbach’s alpha≥0.80; item total correlation 
>0.37). PCA analyses of the CBCL-MS data at ages 11, 13 and 16 years resulted in an 
almost identical factor structure and explained 48.18%, 46.06% and 44.94% of the 
variance of the items respectively. The four factors corresponded to: (1) 
distractibility/ disinhibition (2) psychotic symptoms (3) increased libido (4) disrupted 
sleep. Items’ loading for the four factors are shown in Tables S1-S3. Parallel analyses 
and Kaiser’s criterion both supported the retention of four factors. The scree plot of 
the extracted eigenvalues from the parallel analysis at age 16 is given in Figure S1. Fit 
indices of Confirmatory Factor Analyses (CFA) established good fit of the data [Root 
Mean Square Error of Approximation (RMSEA) values were 0.04, 0.04 and 0.05, and 
Confirmatory Fit index (CFI) values were 0.97, 0.96 and 0.92 for the three assessment 


















Table S3. Items, factors and item loadings of the CBCL-MS at age 16 








41. Impulsive or acts 
without thinking 
.711 .109 .043 .025 
10. Can’t sit still, 
restless or 
hyperactive 
.680 .053 .081 .108 
78. Inattentive or 
easily distracted  
.676 .002 .117 .047 
104. Unusually loud .672 .177 .038 .073 
74. Showing off or 
clowning 
.637 .092 .018 .070 
93. Talks too much .623 .007 .103 -.047 
94. Teases a lot .423 .390 -.145 .159 
87. Sudden changes 
in mood or feelings 
.411 .299 .237 -.093 
96. Thinks about sex 
too much 
.407 -.026 .201 .001 
85. Strange ideas  .028 .662 .301 -.101 
37. Gets in many 
fights  
.290 .534 -.131 .225 
70. Sees things that 
aren’t there  
-.027 .464 .326 -.054 
40. Hears sound or 
voices that aren’t 
there 
-.074 .457 -.054 .137 
89.Suspicious .406 .448 .150 -.169 
34. Feels others are 
out to get him/her 
.384 .436 .055 -.108 
100. Trouble 
sleeping 
.162 .127 .796 .030 
76. Sleep/s less than 
most kids 
.209 .038 .769 .097 
59. Plays with own 
sex parts in public 
.029 .109 .055 .793 
60. Plays with own 
sex parts too much 







Table S4. Items, factors and item loadings of the CBCL-MS at age 13 








41. Impulsive or acts 
without thinking 
.704 .055 .014 .061 
104. Unusually loud .696 -.022 .024 .108 
10. Can’t sit still, 
restless or 
hyperactive 
.695 -.041 .060 .052 
78. Inattentive or 
easily distracted 
.680 .068 .050 .080 
74. Showing off or 
clowning 
.671 .126 -.021 -.029 
93. Talks too much .597 -.033 -.035 .158 
94. Teases a lot .561 .213 .120 -.053 
87. Sudden changes 
in mood or feelings 
.489 .169 -.013 .226 
89.Suspicious .406 .394 -.087 .152 
37. Gets in many 
fights 
.399 .273 .119 -.122 
96. Thinks about sex 
too much 
.313 .176 .272 -.048 
70. Sees things that 
aren’t there 
-.003 .789 -.063 .025 
40. Hears sound or 
voices that aren’t 
there 
-.036 .664 .140 .056 
34. Feels others are 
out to get him/her 
.116 .497 .050 .095 
85. Strange ideas .347 .371 -.023 .107 
60. Plays with own 
sex parts too much 
-.017 .076 .842 .045 
59. Plays with own 
sex parts in public 
.054 -.029 .825 .015 
76. Sleeps less than 
most kids 
.097 .117 .014 .827 
100. Trouble 
sleeping 







Table S5. Items, factors and item loadings of the CBCL-MS at age 11 








104. Unusually loud .750 .128 .049 .055 
74. Showing off or 
clowning 
.706 .140 .046 .048 
10. Can’t sit still, 
restless or 
hyperactive  
.681 .017 .077 .055 
78. Inattentive or 
easily distracted 
.678 .076 .064 .049 
41. Impulsive or acts 
without thinking  
.676 .138 .034 .098 
94. Teases a lot .628 .078 .041 .031 
93. Talks too much .585 .047 .072 .075 
87. Sudden changes 
in mood or feelings 
.532 .306 .094 -.086 
37. Gets in many 
fights 
.524 .037 .001 .179 
70. Sees things that 
aren’t there 
.027 .706 .073 .053 
40. Hears sound or 
voices that aren’t 
there 
-.071 .685 .018 .182 
85. Strange ideas .185 .539 .070 .086 
89.Suspicious .329 .483 .100 -.039 
34. Feels others are 
out to get him/her 
.392 .470 .031 -.108 
76. Sleeps less than 
most kids 
.138 .067 .857 .030 
100. Trouble 
sleeping 
.065 .166 .843 .009 
60. Plays with own 
sex parts too much 
.082 .041 -.034 .825 
59. Plays with own 
sex parts in public 
.003 .214 -.050 .703 
96. Thinks about sex 
too much 











Characteristics of patients with Bipolar Disorder per class  
Table S6. Characteristics of cases with syndromal BD by age 19 according to class 
membership at age 11 






BD cases arising 










% of all cases with Bipolar Disorder in the 
TRAILS sample 
16.2 38.37 17.4 
Male: Femalea 1.0:1.0 1.0:0.7 1.0:1.1 
% High SESb 35.3 52.9 11.8 
IQ
c
 98.29 (14.06) 95.18 (12.30) 97.40 (14.25) 
% Parental Psychiatric Morbidityd 15.6 53.1 31.2 
Age of Onset of BD (years)e 15.57 (2.06) 15.45 (2.33) 15.67 (2.22) 




11.8 52.9 35.3 
Continuous data are presented as mean (standard deviation); Categorical data are presented as proportions (%) across classes; 
aχ2=0.57, p=0.75; bχ2=3.84, p=0.43 cF(2,59)=0.33,p=0.72;
 dχ2=2.78, p=0.25; eF(2,59)=0.05, p=0.95; 












This chapter will commence by presenting a summary of the main findings of the 
thesis. Next, the main strengths and limitations of the studies comprising Chapters 4 
to 6 (Chapter 4.Child Behavior Checklist- Mania Scale (CBCL-MS): Development and 
validation of a population-based scale for bipolar disorder; Chapter 5. Alarm 
Symptoms in the Early Diagnosis of Bipolar Disorder: A Population Based Cohort 
Study; and Chapter 6. Trajectories to Bipolar Disorder from Childhood to 
Adulthood) will be highlighted, followed by an integration of the results. The chapter 
will conclude by outlining future directions and suggesting priorities of research in 
this field.   
 
7.2 Summary of the main findings 
Numerous implications of the studies comprising this thesis have been discussed in 
the previous chapters; overall, there are six main findings. Firstly, I have now 
developed a new scale, termed CBCL-MS, which measures manic symptomatology 
using 19 items of the widely used CBCL 6-18 (Achenabch & Rescorla, 2001). This scale 
improves already existing scoring algorithms using the CBCL to measure manic 
symptomatology (Biederman et al., 1995; Faraone et al., 2005; Kim et al., 2012) and 
therefore it posits a great step forward in the attempts to develop better assessment 
tools for common mental disorders. Most importantly it is based on items of the 
CBCL which is a widely used instrument that has been translated in over 90 
languages and has cross-cultural generilisability (De Groot et al., 1994). The 
structural model of the CBCL-MS consisted of four factors. These factors correspond 
to dimensions of distractibility/disinhibition, psychosis, increased libido and 
disrupted sleep. The factor structure of the CBCL-MS showed remarkable temporal 
stability between the ages of 11 to 16. It also presented with good internal 






Secondly, I have successfully identified a group of children aged 11 years that are at 
high risk to develop BD one to eight years after the initial assessment using the CBCL-
MS.  Specifically, using a Latent Class Analysis to empirically characterize children 
based on parental endorsement of subclinical manic manifestations, a ‘mildly 
symptomatic’ and a ‘highly symptomatic’ class of children were extracted who were 
2.7 and 7.1 times, respectively, more likely to develop BD by age 19 years in 
comparison to the reference ‘asymptomatic’ class. Children in the ‘highly 
sympotmatic’ class were also characterized by a confluence of sociognitive and 
familial risk factors, including lower IQ, worse family functioning, low socioecomonic 
status and higher rates of parental psychiatric morbidity. 
 
Thirdly, we introduced the concept of ‘alarm symptoms’ for BD by drawing example 
from research in the early detection of cancer which can be used to formulate 
prevention strategies pending more detailed biological validation (Post et al., 2013). 
These included clustering of CBCL-MS items of hyperactivity, impulsivity, clowning, 
reduced sleep, mood lability and increased and loud speech that were endorsed with 
a probability of ≥ 0.3 resulting in standardized CBCL-MS total score ≥70.  The positive 
and negative predictive value of the “alarm symptoms” identified was 13.2% and 
96.3% respectively.   
 
Fourthly, class membership was a significant predictor of BD but not of major 
depressive disorder, general anxiety disorder or substance abuse. This specificity of 
prediction represents an additional step forward in the study of mental disorders as 
most familial and non-familial risk factors have been shown to predict multiple 
adverse outcomes.  Such a pluripotent effect of risk factors has been shown, for 
example, for  family history of schizophrenia which increases the probability of 
multiple other adverse mental health outcomes (Dean et al., 2010).   
 
Moreover, I have shown that manic symptoms in adolescent populations are 






Finally, by charting the trajectories of manic symptomatology spanning from late 
childhood to late adolescence I have demonstrated that youths who do not convert 
to BD show a decrease in the numbers of psychopathology during adolescence while 
those who converts evidence persistence but no exacerbation of subclinical manic 
symptoms.  
 
7.3 Strengths and Limitations 
 7.3.1 Strengths 
The studies presented as part of this thesis present with multiple strengths and 
advantages. Firstly, I advocated a life course approach to the study of BD which, as 
described in Chapter 1, presents with several advantages over cross-sectional 
research designs. Additionally, the analytical procedures followed were chosen 
carefully and I did not solely rely on traditional univariate linear analyses that do not 
reflect the full complexity of the events by relying on rather strict assumptions of 
error free variables (Bollen and Curran, 2006).  The longitudinal collection of data by 
TRAILS also adds value to the study of the course of manic symptoms over early life 
stages. Traditionally, longitudinal study designs have been shown to provide more 
efficient estimators than cross-sectional designs with same number and pattern of 
observations; in addition, they also allow the identification of aging effects (changes 
over time within individuals) from cohort effects (differences between subjects at 
baseline)  and have therefore the potential to provide information about individual 
change (Hedeker et al., 2004).  
 
Moreover, the sample of TRAILS is a large representative community sample that 
provided the ideal ground for generating and testing aetiological models for mental 
health. Gender and sociodemographic variables were adequately represented in the 
sample and the prevalence rate of 5.4% for BD coincides with the one reported in a 
recent epidemiological study of US adolescents (Kessler et al., 2009) providing 
additional support for the representativeness of the sample. The sample size was 





Moreover, this study provides unique insight in the study of BD as it examined the 
longitudinal course of subclinical manic symptoms, while incorporating risk factors in 
the analytical process to account for the additional variance explained by these 
variables. These variables included socioeconomic status, cognitive abilities, family 
history of psychopathology and family functioning which have been consistently 
shown to be associated with increased risk and/or worse prognosis for patients with 
BD (Du Rocher Schudlich et al., 2008; Koenen et al., 2009; Kumar and Frangou 2010; 
Bauer et al. 2011). These variables were adequately measured with instruments, 
which have been shown to have excellent psychometric properties (see Chapter 3).  
 
7.3.2 Limitations 
The results of this thesis and their implications should be viewed in light of its 
limitations. Firstly, the study period does not cover the full risk period for BD and it is 
possible that further cases may present in the future. In fact, while BD commonly 
begins in adolescence with a modal age of onset between 16 and 20 years (Roy-
Byrne et al., 2007; Mesman et al., 2013), almost half of the patients with Bipolar-I 
have reported an age of onset after the age of 25 years in the world mental health 
survey initiative (Merikangas et al., 2011). Therefore, our results are limited to what 
would be considered to be early onset BD in the available literature. 
 
Inherent in research in social sciences are also limitations of the instruments used 
including measurement error and assessment biases. For example, despite its 
widespread use, the CIDI is limited by its structured format and its administration by 
lay interviewers who may not probe or interpret further participant responses. In 
addition, Kessler et al. (2006) have highlighted that the positive predictive value of 
the CIDI-based screening scales is likely to vary across populations as a function of 
the prevalence of the targeted disorder and therefore the estimates of BD found in 





Other sources of error could have related to the informant. For the studies of this 
thesis I used parental reports of symptoms captured with items of the CBCL 6-18 to 
measure subclinical manic symptomatology. Research suggests that no single rater 
can provide a complete picture of the child's behavior and, more importantly, that 
parents commonly assess different aspects of the child's behavior (Bartels et al., 
2003). In order to tackle this limitation it is important for future studies to validate 
the findings of my work using data from multiple sources such as teacher ratings or 
self-reports. For this purpose, other assessment tools included in the Achenbach 
System of Empirically Based Assessment (ASEBA) battery of tests, e.g. the Teacher 
Report Form (TRS) or the Youth Self-Repost (YSR) can be used (Achenbach, 1991).  
 
Subject loss at follow-up assessments is also a common form of selection bias in 
longitudinal study designs (Kristman et al., 2004). Acceptable follow-up rates have 
been recommended to be from 50% (Babbie, 1990) to 80% (Altman, 2000). However, 
at 84.3% almost 10 years after the baseline assessment, attrition rate has been kept 
very low in TRAILS.  In addition, missing data were treated appropriately in order to 
correct for bias and minimize error (Chapter 3.6).  
 
7.4 Integration of Findings 
The findings of the studies presented in this thesis build on the currently available 
body of literature on the measurement and course of BD and expand them in new 
directions. The development of the CBCL-MS is a significant step forward in the 
attempts to develop valid and reliable and assessment tools for psychiatric 
symptomatology. Particularly for BD, there are numerous scales available that have 
been shown to have moderate to good predictive value and discriminant ability with 
manic symptomatology (Youngstrom et al., 2004). These include the Parent Young 
Mania Rating Scale (P-YMRS; Gracious et al., 2002;), the Parent General Behavior 
Inventory (P-GBI) (Youngstrom et al., 2001), the Adolescent General Behavior 
Inventory (A-GBI) (Danielson et al., 2003), the Youth Self Report (YSR) (Achenbach et 
al., 1991), the Teacher Report Form (TRF) (Achenbach et al., 1991), the Childhood 
Mania Rating Scale (CMRS) (Pavuluri et al., 2006), the Mood Disorder Questionnaire- 





The psychometric properties of the newly developed CBCL-MS compare to the ones 
achieved by widely used instruments, e.g. the MDQ, in large community samples 
(Hirschfeld et al., 2003). Most importantly, the CBCL-MS was developed using items 
of the widely used CBCL 6-18 (Achenbach, 1991) and constitutes a better scoring 
algorithm for BD than the already existing ones, i.e. the CBCL-Pediatric Bipolar 
Disorder (Faraone et al.,2005) and the Externalising Scale of the CBCL (Diler et al., 
2009).    
 
Noticeably, the CBCL-MS could not differentiate participants with BD from those 
with ADHD confirming that the relationship between these two disorders is complex.  
More evidence on the suggested overlap in the symptoms of the two disorders 
particularly with regards to increased activity, talkativeness and mood dysregulation 
(WHO, 1992; APA, 1994) stemmed from the analyses in Chapter 5. A large proportion 
of children in the highly symptomatic class had childhood diagnoses of disruptive 
behavior disorders, particularly ADHD.  It would therefore appear that behavioral 
measures and risk factors, even when considered together, do not allow sufficient 
separation between ADHD and childhood antecedents of BD. This suggests that 
either the two disorders have overlapping pathophysiology or that measures with 
greater biological specificity are needed to differentiate between the two (Skirrow et 
al., 2012).    
 
Moreover, membership to the highly symptomatic risk class (Chapter 5) was not 
associated with higher risk for future major depressive disorder, general anxiety 
disorder or substance abuse; yet, 62 individuals (30%) of this class had such non-BD 
diagnoses by age 19.  In combination with findings suggesting that subclinical BD 
symptoms are associated with elevated impairment, comorbidity, and suicide 
attempts (Lewinsohn et al., 2003), this type of classification might prove very useful 
from a public health perspective.  
 
In addition, the frequent endorsement of subclinical manic symptoms, particularly 




suggesting that subclinical manic symptomatology is common in adolescence (Tijssen 
et al., 2010a) and highlights the possible advantages of expanding the concept of 
syndromal BD to include subthreshold manic-like pathology and BD-NOS in children 
and adolescents (Angst et al., 2003; Geller et al. 2007; Stringaris et al. 2010). 
Specifically, Stringaris et al. (2010) demonstrated that by relaxing the duration 
criterion the prevalence of youths with BD-NOS was 10-times higher than the 
prevalence of actual BD. Youths with BD-NOS demonstrated very poor overall social 
functioning emphasizing further the need to follow-up the children of my study 
belonging to the highly symptomatic class and assess their functional and psychiatric 
outcome over a longer period of time.   
 
Finally, with regards to the subclinical manic symptoms charted in Chapter 6, our 
findings suggest that subclinical manic symptomatology in asymptomatic or mildly 
symptomatic children at age 11 follow similar longitudinal trajectories for those who 
convert to BD and those who do not. In contrast, converters in the highly 
symptomatic class showed persistence of subclinical symptomatology prior to BD 
onset while non-converters evidenced a rapid decrease. These findings build on the 
evidence reviewed in Chapter 6 which suggests that the odds for conversion increase 
with the degree of persistence of manic symptoms (Tijssen et al., 2010b). 
Specifically, this pattern was confirmed only for children in the highly symptomatic 
class who subsequently converted to BD, emphasizing the importance of more 
person centred-approaches in the study of longitudinal change and rate of change of 
psychopathology and therefore in the identification of future strategies for early 
identification and prevention. 
  
7.5 Future Directions 
The studies presented as part of this thesis build on the existing literature and open 
up interesting new avenues in the study of BD. In this section I will highlight the main 
research priorities as exemplified by the results presented. 
 
Firstly, the CBCL-MS should be tested in other epidemiological samples to establish 




tested in clinical samples to examine whether it can also serve as a diagnostic 
instrument complentary to other established clinical diagnostic instruments. 
Convergence with valid and reliable instruments as well as inter-rater agreement 
rates would be essential in this process (Kline, 1988). The discriminative abilities of 
the scale have the potential to improve greatly as a result of the increased base rate 
which is directly tied to the positive and negative predictive values of a screening 
instrument (Glaros & Kline, 1988).  
 
Future studies should also follow and assess children in the highly symptomatic class 
to examine whether the conversion rates, and therefore the positive predictive 
value, increase due to additional cases presenting with BD in the next years. Since 
the period covered by the assessments in TRAILS do not cover the full risk period for 
BD it is possible that youths in the highly symptomatic class haven’t converted to BD 
as yet.  
 
Moreover, it would be pertinent to identify additional unique characteristics of 
children in the highly symptomatic class who convert to clinically meaningful BD. 
These characteristic could extend beyond the sociodemographic, familial and 
cognitive characteristics included in the analyses of my studies to include 
neuroimaging and/or genetic data. Recent studies have identified genetic risk factors 
(Kakiuchi et al., 2003; Schumacher et al., 2004; Moskvina et al., 2008) as well as 
structural and functional brain abnormalities (Strakowski et al., 2004) that are 
associated with an increased risk of BD. This type of cross-disciplinary research 
combing epidemiological psychiatric research with research in genetic markers and 
neuroimaging can expand my results by identifying additional risk markers or 
resilience factors for BD and therefore explain more variability in the mechanisms 
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